{"gene":"NPPC","run_date":"2026-04-29T11:37:57","timeline":{"discoveries":[{"year":1991,"finding":"CNP (encoded by NPPC) selectively and potently activates the ANPR-B (NPR-B/GC-B) guanylyl cyclase receptor, with 50- to 500-fold higher affinity for NPR-B than ANP or BNP respectively, and does not stimulate cGMP accumulation via ANPR-A (NPR-A/GC-A).","method":"Cell-based cGMP accumulation assay and receptor binding competition in cells expressing recombinant human ANPR-A or ANPR-B","journal":"Science","confidence":"High","confidence_rationale":"Tier 1 — direct receptor activation assay with quantified binding affinities; foundational paper with 731 citations, replicated across multiple subsequent studies","pmids":["1672777"],"is_preprint":false},{"year":1991,"finding":"Human NPPC encodes a 126-amino acid prepro-CNP precursor processed to yield CNP-22 and CNP-53; the gene contains at least two exons and one intron, with a 5'-flanking region containing an inverted CCAAT box, two GC boxes, and a cAMP response element-like sequence distinct from ANP and BNP gene promoters.","method":"Genomic library cloning, sequencing, and cDNA structure analysis; HPLC-RIA for peptide identification in human brain","journal":"Biochemical and biophysical research communications","confidence":"High","confidence_rationale":"Tier 1 — direct gene/protein characterization with sequencing and peptide identification","pmids":["2018508"],"is_preprint":false},{"year":1991,"finding":"CNP-like immunoreactivity is highest in the anterior pituitary and present throughout the brain, with tissue distribution and processing pattern (yielding CNP and CNP-53) clearly different from ANP and BNP, consistent with a role as a neuropeptide/neuromodulator rather than a cardiac hormone.","method":"Specific radioimmunoassay (RIA) for CNP, HPLC-gel permeation chromatography to resolve molecular forms in rat and human tissues","journal":"Endocrinology","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal biochemical methods (RIA + HPLC) across multiple tissues; foundational tissue distribution paper","pmids":["1855454"],"is_preprint":false},{"year":1990,"finding":"Rat NPPC encodes a 126-residue precursor with a 23-residue signal sequence; CNP mRNA is expressed exclusively in the brain (by Northern blot), suggesting CNP functions as a CNS neuropeptide.","method":"cDNA library cloning, sequencing, RNA blot hybridization","journal":"FEBS letters","confidence":"High","confidence_rationale":"Tier 1 — direct molecular cloning and sequence determination with expression analysis","pmids":["1702395"],"is_preprint":false},{"year":1990,"finding":"CNP potently increases cGMP levels and stimulates guanylate cyclase activity in the particulate fraction of rat vascular smooth muscle cells (VSMC), with maximum activation 4-fold higher than ANP, establishing CNP as a potent cGMP stimulator specifically in VSMC.","method":"Cell-based cGMP measurement, guanylate cyclase activity assay in particulate fraction of cultured rat VSMC","journal":"Biochemical and biophysical research communications","confidence":"High","confidence_rationale":"Tier 1 — direct enzymatic assay in relevant primary cells; highly cited foundational study","pmids":["2164803"],"is_preprint":false},{"year":1992,"finding":"CNP binds with highest affinity to NPR-B (GC-B) and activates cGMP production via NPR-B with rank order CNP > ANP ≥ BNP; CNP binds NPR-C clearance receptor with intermediate affinity (ANP > CNP > BNP); species differences exist in receptor selectivity, particularly for BNP.","method":"Radioligand binding competition assays and cGMP production assays using receptor preparations from human, bovine, and rat tissues and cultured cells; Northern blot for receptor expression","journal":"Endocrinology","confidence":"High","confidence_rationale":"Tier 1 — comprehensive binding and functional assays across species; 696 citations","pmids":["1309330"],"is_preprint":false},{"year":1992,"finding":"Human NPPC gene is located on chromosome 2 (later refined to 2q37.1) and encodes a 126-amino acid prepro-CNP; the 5'-flanking region contains cis-regulatory elements (inverted CCAAT box, GC boxes, cAMP response element-like sequence) absent in ANP and BNP gene promoters. CNP is the dominant natriuretic peptide in human brain.","method":"Genomic cloning, sequencing, somatic hybrid cell chromosome mapping, HPLC-RIA for peptide identification in human brain","journal":"Hypertension","confidence":"High","confidence_rationale":"Tier 1 — direct gene characterization with chromosomal mapping and peptide identification","pmids":["1339402"],"is_preprint":false},{"year":1993,"finding":"CNP is the major natriuretic peptide in human cerebrospinal fluid (CSF), present at ~10-fold higher concentration than ANP or BNP in CSF, while CNP is undetectable in plasma, supporting a primary CNS paracrine/autocrine role for NPPC-derived CNP.","method":"Specific radioimmunoassay (RIA) measurement of ANP, BNP, and CNP in matched CSF and plasma samples from patients","journal":"Brain research","confidence":"High","confidence_rationale":"Tier 2 — direct quantitative measurement establishing compartmentalization of CNP expression","pmids":["8330189"],"is_preprint":false},{"year":1994,"finding":"Mouse NPPC (Nppc) gene maps to chromosome 1, is composed of at least two exons and one intron, with conserved 5'-flanking regulatory elements; comparison with human NPPC reveals conserved and divergent regions. Human NPPC maps to chromosome 2.","method":"Genomic library cloning, sequencing, PCR-based microsatellite polymorphism analysis in recombinant inbred mouse strains, somatic hybrid cell chromosome mapping","journal":"Genomics","confidence":"High","confidence_rationale":"Tier 1 — direct molecular characterization and chromosomal mapping","pmids":["7698765"],"is_preprint":false},{"year":1994,"finding":"CNP is produced in the anterior pituitary predominantly by gonadotropes (co-localized with LH); pituitary cells express GC-B (NPR-B) but not GC-A; CNP potently stimulates cGMP in gonadotropes, suggesting an autocrine role. Selective destruction of gonadotropes reduced both CNP-stimulated cGMP production and GnRH-stimulated LH release.","method":"RT-PCR for CNP precursor mRNA, immunohistochemistry with co-localization of CNP and LH, targeted toxin (GnRH-ricin A conjugate) to selectively ablate gonadotropes, cGMP accumulation assay","journal":"Endocrinology","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods including cell-type specific ablation with functional readout","pmids":["7988473"],"is_preprint":false},{"year":1996,"finding":"CNP stimulates cGMP production in osteoblast-like cells via NPR-B, inhibits DNA synthesis in a dose-dependent manner, and promotes osteoblast differentiation markers (alkaline phosphatase activity, osteocalcin mRNA, mineralization); these effects are mimicked by 8-bromo-cGMP, establishing a cGMP-mediated signaling pathway for CNP in bone formation. CNP-like immunoreactivity is detected in conditioned medium from osteoblasts.","method":"cGMP accumulation assay, DNA synthesis (thymidine incorporation), alkaline phosphatase activity assay, Northern blot for gene expression, mineralization nodule quantification in cultured rat calvarial osteoblasts","journal":"American journal of physiology","confidence":"High","confidence_rationale":"Tier 1-2 — multiple functional assays with cGMP analog confirmation of mechanism","pmids":["8967430"],"is_preprint":false},{"year":1995,"finding":"Shear stress (24 dyne/cm²) markedly induces NPPC mRNA expression in human umbilical vein endothelial cells within 3 hours, maintained through 12 hours, identifying hemodynamic flow as a transcriptional regulator of CNP gene expression.","method":"Cone-plate viscometer shear stress exposure of HUVEC; CNP mRNA quantification by RT-PCR","journal":"FEBS letters","confidence":"Medium","confidence_rationale":"Tier 2 — direct experimental manipulation with molecular readout; single lab study","pmids":["7589445"],"is_preprint":false},{"year":1999,"finding":"Shear stress induction of NPPC mRNA in endothelial cells is independent of NO autocrine signaling (not blocked by L-NAME or genistein) but is attenuated 71% by intracellular calcium chelation (BAPTA/AM), implicating calcium-dependent signaling in flow-mediated CNP transcriptional regulation. Dexamethasone potentiates shear-stress-induced CNP mRNA 2-fold.","method":"Defined laminar shear stress (25 dyn/cm²) of bovine aortic endothelial cells; PhosphorImager quantification of CNP/GAPDH mRNA ratio; pharmacological inhibition of NO synthase, tyrosine kinase, calcium signaling; CNP secretion measurement by RIA","journal":"Annals of biomedical engineering","confidence":"Medium","confidence_rationale":"Tier 2 — multiple pharmacological probes dissecting signaling pathway; single lab","pmids":["10468226"],"is_preprint":false},{"year":2001,"finding":"Crystal structure of NPR-C extracellular domain bound to CNP reveals that a single CNP molecule binds asymmetrically at the interface of a symmetric NPR-C dimer, inducing a 20 Å closure between membrane-proximal domains; each monomer contains a molecular spring (linker peptide) that is an allosteric trigger for intracellular signaling.","method":"X-ray crystallography at 2.9 Å (unliganded) and 2.0 Å (CNP-bound) resolution; hormone-binding thermodynamics","journal":"Science","confidence":"High","confidence_rationale":"Tier 1 — high-resolution crystal structures with functional thermodynamic validation","pmids":["11533490"],"is_preprint":false},{"year":2003,"finding":"Furin is the critical intracellular endoprotease responsible for processing pro-CNP to mature CNP. Pro-CNP processing is blocked by furin inhibitors, absent in furin-deficient LoVo cells, and restored by recombinant furin expression; corin (the ANP convertase) does not process pro-CNP. Furin-processed CNP is biologically active in cGMP assays.","method":"Recombinant expression in HEK293 and SW1353 cells; furin inhibitor treatment; expression in furin-deficient LoVo cells with reconstitution; incubation with purified recombinant furin; Western blot; cell-based cGMP bioassay","journal":"Journal of Biological Chemistry","confidence":"High","confidence_rationale":"Tier 1 — reconstitution experiment with purified enzyme plus loss-of-function/gain-of-function in multiple cell lines; 167 citations","pmids":["12736257"],"is_preprint":false},{"year":2003,"finding":"CNP overexpression in chondrocytes rescues dwarfism in achondroplasia mice (activated FGFR3) by correcting decreased extracellular matrix synthesis in the growth plate through inhibition of the MAPK pathway of FGF signaling; CNP does not affect the STAT-1 pathway of FGFR3 signaling.","method":"Transgenic chondrocyte-specific CNP overexpression in FGFR3-activated achondroplasia mouse model; bone length measurement; immunohistochemistry; Western blot for phospho-ERK (MAPK) and STAT-1 pathway markers","journal":"Nature Medicine","confidence":"High","confidence_rationale":"Tier 2 — genetic rescue experiment with pathway-specific pharmacological/molecular dissection; 303 citations","pmids":["14702637"],"is_preprint":false},{"year":2004,"finding":"CNP inhibits endothelin-1 (ET-1)-induced cardiac myocyte hypertrophy via a cGMP-dependent mechanism, suppressing protein synthesis, ANP secretion, GATA-4/MEF-2 DNA binding, CaM kinase II activity, ERK phosphorylation, and intracellular Ca²⁺ increase. Conversely, ET-1 suppresses CNP-induced cGMP accumulation through a protein kinase C- and Ca²⁺-dependent mechanism, establishing mutual interference between CNP and ET-1 signaling pathways.","method":"Cultured neonatal rat cardiac myocytes; protein synthesis assay (³H-leucine), ANP secretion RIA, EMSA for transcription factor binding, CaM kinase II activity assay, ERK phosphorylation by Western blot, intracellular Ca²⁺ imaging, cGMP measurement; 8-bromo-cGMP as mechanistic probe; PKC activator and Ca²⁺ ionophore experiments","journal":"Endocrinology","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal assays in primary cardiomyocytes with bidirectional pathway dissection","pmids":["14749356"],"is_preprint":false},{"year":2007,"finding":"Overexpression of NPPC (due to balanced translocation disrupting a negative regulatory element on chromosome 2q37.1) leads to doubled plasma CNP concentration and a Marfanoid overgrowth phenotype in humans; transgenic mice with NPPC overexpression in bone recapitulate this phenotype, directly linking elevated CNP levels to skeletal overgrowth.","method":"FISH and array-CGH characterization of translocation; breakpoint cloning and sequencing; plasma CNP measurement by RIA; NPPC mRNA quantification in patient fibroblasts; phenotype analysis of NPPC-overexpressing transgenic mice","journal":"Human Mutation","confidence":"High","confidence_rationale":"Tier 2 — human genetics plus transgenic mouse model with quantitative CNP measurement; 102 citations","pmids":["17373680"],"is_preprint":false},{"year":2007,"finding":"A cluster of translocation breakpoints near NPPC in 2q37.1 causes NPPC overexpression in multiple patients with similar overgrowth phenotype, consistent with separation from a negative regulatory element on chromosome 2 as the causative mechanism.","method":"Cytogenetic analysis, molecular breakpoint characterization, NPPC expression quantification in patient-derived cells","journal":"Human Mutation","confidence":"Medium","confidence_rationale":"Tier 2 — multiple patients with same mechanism; extends prior single-patient finding","pmids":["17676597"],"is_preprint":false},{"year":2008,"finding":"The lbab mouse mutation (R-to-G substitution in conserved CNP coding region) causes dwarfism by reducing CNP's ability to bind and activate NPR-B: 10-fold more CNP(lbab) is required to compete for receptor binding, and 30- to >100-fold more is required to activate NPR-B in cGMP assays. Molecular modeling suggests the conserved arginine is critical for binding an acidic pocket in NPR-B.","method":"Whole-cell cGMP elevation assay, membrane guanylyl cyclase activity assay, radioligand competition binding with [¹²⁵I]CNP, molecular modeling","journal":"Peptides","confidence":"High","confidence_rationale":"Tier 1 — in vitro receptor binding and enzymatic assays with defined mutant peptide; mechanistic explanation of dwarfism phenotype","pmids":["18554750"],"is_preprint":false},{"year":2008,"finding":"The lbab/lbab mouse spontaneous mutation is a hypomorphic Nppc mutation retaining only slight CNP activity for cGMP production; transgenic rescue with chondrocyte-specific CNP expression fully compensates the dwarf phenotype, confirming NPPC loss-of-function causes dwarfism through impaired endochondral ossification with markedly reduced proliferative and hypertrophic chondrocyte zones.","method":"Transgenic rescue experiment; cGMP production assay for lbab CNP activity; histological analysis of growth plate; bone length measurement","journal":"Biochemical and biophysical research communications","confidence":"High","confidence_rationale":"Tier 2 — genetic rescue definitively links Nppc mutation to phenotype with mechanistic characterization","pmids":["18775416"],"is_preprint":false},{"year":2009,"finding":"CNP acts as a bifurcation factor for sensory neurons: CNP activates a cGMP signaling cascade via NPR2 (GC-B) that is essential for sensory axon bifurcation at the dorsal root entry zone (DREZ) of the spinal cord, but does not affect collateral formation. In CNP mutant mice, bifurcation errors persist at maturity and result in reduced synaptic input on secondary neurons (measured by patch-clamp).","method":"CNP knockout mouse analysis; axon tracing; electrophysiological patch-clamp recordings; genetic comparison with nitric oxide-sensitive guanylyl cyclase (NO-GC) knockouts","journal":"Proceedings of the National Academy of Sciences","confidence":"High","confidence_rationale":"Tier 2 — genetic loss-of-function with specific anatomical and electrophysiological phenotype; pathway dissection via NO-GC comparison","pmids":["19805384"],"is_preprint":false},{"year":2010,"finding":"Mural granulosa cells express NPPC mRNA while cumulus cells express NPR2 (GC-B); CNP increases cGMP in cumulus cells and oocytes and inhibits meiotic resumption in vitro. Graafian follicles of Nppc or Npr2 mutant mice fail to sustain meiotic arrest, with precocious meiotic resumption. Oocyte-derived paracrine factors promote cumulus cell NPR2 expression, establishing a granulosa→cumulus→oocyte paracrine signaling axis.","method":"In situ hybridization and RT-PCR for Nppc/Npr2 expression; cGMP measurement in cumulus cells and oocytes; in vitro meiosis inhibition assay; Nppc and Npr2 knockout mouse phenotyping; conditioned medium experiments with oocyte-derived factors","journal":"Science","confidence":"High","confidence_rationale":"Tier 2 — genetic loss-of-function in two genes with specific cellular phenotype plus in vitro reconstitution; 454 citations","pmids":["20947764"],"is_preprint":false},{"year":2010,"finding":"The local CNP/GC-B system within the growth plate is responsible for physiological endochondral bone growth: cartilage-specific Nppc or GC-B knockout mice have severely shortened bones comparable to systemic knockouts, with drastically reduced hypertrophic chondrocyte layers and moderately reduced proliferative layers. Circulating CNP from transgenic mice with liver-specific NPPC overexpression can rescue impaired bone growth and reduce mortality of CNP knockout mice, demonstrating that systemic CNP delivery is sufficient.","method":"Cartilage-specific conditional knockout mice for Nppc and NPR2 (GC-B); bone length measurement; histological growth plate analysis; BrdU proliferation assay; rescue by SAP-Nppc transgenic mice (systemic CNP); survival analysis","journal":"Endocrinology / Scientific Reports","confidence":"High","confidence_rationale":"Tier 2 — tissue-specific genetic knockouts with mechanistic cellular analysis plus systemic rescue experiment","pmids":["20610569","26014585"],"is_preprint":false},{"year":2011,"finding":"The pre-ovulatory LH/hCG surge decreases CNP secretion by granulosa cells to promote meiotic resumption: LH/hCG treatment decreases NPPC transcripts in mural granulosa cells and ovarian CNP content; CNP treatment of cumulus-oocyte complexes inhibits meiosis resumption with increased cGMP in both cumulus cells and oocytes. In human ovaries, CNP in follicular fluid decreases following ovulatory hCG dose.","method":"Genome-wide microarray analysis of periovulatory ovaries; RT-PCR quantification of NPPC; RIA for ovarian CNP; in vitro meiosis inhibition assay; cGMP measurement; human follicular fluid CNP measurement","journal":"Human Reproduction","confidence":"High","confidence_rationale":"Tier 2 — multiple species (mouse and human), multiple methods; mechanistic link from LH to CNP regulation established","pmids":["21865234"],"is_preprint":false},{"year":2012,"finding":"CNP/NPR2 signaling maintains oocyte meiotic arrest from early antral follicle stages; Npr2 mutant mice show precocious meiotic resumption in early antral follicles. Amphiregulin (an LH/hCG mediator acting via EGFR) suppresses NPPC mRNA levels in cultured granulosa cells, establishing the LH→EGFR→amphiregulin→decreased NPPC→meiotic resumption pathway.","method":"In situ hybridization and RT-PCR for Nppc/Npr2 in ovaries at different follicular stages; histological phenotyping of Npr2 mutant mice; hCG treatment of immature mice with quantification of NPPC mRNA; amphiregulin treatment of cultured granulosa cells","journal":"Molecular Reproduction and Development","confidence":"High","confidence_rationale":"Tier 2 — genetic model plus pharmacological pathway dissection with molecular readouts","pmids":["22987720"],"is_preprint":false},{"year":2012,"finding":"NPPC/NPR2 signaling is essential for oocyte meiotic arrest and cumulus oophorus formation: Nppc(lbab) and Npr2(cn) mutant mice ovulate oocytes with fragmented/degenerated ooplasm that fail to develop past the two-cell stage; oocytes in antral follicles prematurely resume meiosis with disorganized chromosomes; ovulated oocytes lack cumulus cells.","method":"Phenotypic analysis of Nppc and Npr2 mutant mice; histology of ovaries; oocyte developmental competence assay (fertilization and two-cell development)","journal":"Reproduction","confidence":"High","confidence_rationale":"Tier 2 — two independent genetic mutants with detailed cellular phenotyping","pmids":["22696190"],"is_preprint":false},{"year":2012,"finding":"A CNP analog (BMN 111) resistant to neutral endopeptidase (NEP) degradation inhibits MAPK pathway activation (decreased pERK1/2) in human achondroplasia growth-plate chondrocytes and rescues bone growth in Fgfr3(Y367C/+) achondroplasia mice, confirming the CNP→NPR-B→cGMP→MAPK inhibition mechanism as therapeutically relevant.","method":"ERK1/2 phosphorylation assay in human achondroplasia chondrocytes; bone growth measurement in Fgfr3 mutant mice treated with BMN 111; skeletal analysis including growth plate histology","journal":"American Journal of Human Genetics","confidence":"High","confidence_rationale":"Tier 2 — pharmacological validation in human cells and mouse model; 153 citations","pmids":["23200862"],"is_preprint":false},{"year":2013,"finding":"CNP infusion in failing rat hearts increases cGMP and produces a negative inotropic response (NIR) and positive lusitropic response (LR) via PKG-mediated phosphorylation of phospholamban (PLB Ser16) and troponin I (TnI Ser23/24); SERCA2 activity is essential for both responses, as shown by SERCA inhibition (thapsigargin) and cardiomyocyte-specific SERCA2 gene inactivation. CNP increases Ca²⁺ transient amplitude and SERCA2 activity.","method":"Muscle strip contractility measurements; cGMP level assay; Ca²⁺ transient imaging; Western blot for PLB and TnI phosphorylation; SERCA inhibitor (thapsigargin) experiments; cardiomyocyte-specific SERCA2 knockout mice; PKG blocker experiments","journal":"British Journal of Pharmacology","confidence":"High","confidence_rationale":"Tier 1-2 — multiple orthogonal assays including genetic SERCA2 deletion validating mechanism","pmids":["23808942"],"is_preprint":false},{"year":2015,"finding":"The local CNP/GC-B system in the growth plate is responsible for physiological endochondral bone growth; cartilage-specific GC-B (NPR-B) knockout mice are shorter than cartilage-specific CNP knockout mice, indicating that GC-B in the growth plate may also respond to signals beyond local CNP.","method":"Cartilage-specific conditional knockout mice for Nppc and NPR2 (GC-B); bone length measurement; growth plate histology; comparison with systemic knockouts; BrdU proliferation assay","journal":"Scientific Reports","confidence":"High","confidence_rationale":"Tier 2 — tissue-specific genetic knockouts with quantitative bone analysis","pmids":["26014585"],"is_preprint":false},{"year":2017,"finding":"Two heterozygous NPPC mutations in the conserved CNP ring region cause autosomal dominant short stature in humans; both mutations show significant reductions in cGMP synthesis when tested functionally, confirming loss-of-function pathogenicity. One mutation corresponds to the lbab mouse mutation.","method":"NPPC sequencing in 668 patients (357 disproportionate short stature, 311 ISS) plus exome sequencing; cGMP production assay for functional validation of mutant CNP peptides; co-segregation analysis in families","journal":"Genetics in Medicine","confidence":"High","confidence_rationale":"Tier 1-2 — direct functional assay of mutant CNP with cGMP measurement plus human genetic co-segregation","pmids":["28661490"],"is_preprint":false},{"year":2017,"finding":"Elevated circulatory CNP (from liver-specific NPPC transgenic mice) rescues craniofacial hypoplasia in achondroplasia (Fgfr3ach) mice by restoring spheno-occipital synchondrosis thickness, promoting chondrocyte proliferation in craniofacial cartilage, and ameliorating foramen magnum stenosis, demonstrating that systemic CNP promotes endochondral ossification in craniofacial as well as appendicular bone.","method":"Fgfr3ach mice crossed with SAP-Nppc-Tg mice (systemic CNP); craniofacial morphometric analysis; synchondrosis histology; chondrocyte proliferation assay","journal":"Journal of Dental Research","confidence":"High","confidence_rationale":"Tier 2 — genetic rescue experiment with quantitative anatomical analysis","pmids":["28644737"],"is_preprint":false},{"year":2021,"finding":"Tristetraprolin (TTP/ZFP36) mediates LH-surge-induced degradation of Nppc mRNA in mural granulosa cells: LH/hCG transiently upregulates Zfp36 mRNA; TTP directly targets a rare non-canonical AU-rich element in the Nppc 3' UTR to destabilize Nppc mRNA; MGC-specific Zfp36 knockout and lentiviral knockdown impair LH-induced Nppc mRNA decline and oocyte meiotic resumption. LH activates Zfp36/TTP via the EGFR-ERK1/2-dependent pathway.","method":"Gain- and loss-of-function of Zfp36 in MGCs; MGC-specific Zfp36 conditional knockout mice; in vivo lentiviral knockdown; RNA-binding assay (TTP binding to Nppc 3' UTR); mRNA stability assay; oocyte meiotic resumption phenotyping; pathway dissection with EGFR-ERK inhibitors","journal":"Proceedings of the National Academy of Sciences","confidence":"High","confidence_rationale":"Tier 2 — genetic loss-of-function plus direct RNA-binding assay establishing molecular mechanism of Nppc mRNA regulation","pmids":["34031239"],"is_preprint":false},{"year":2022,"finding":"CNP, but not BNP, increases cGMP near troponin I (TnI) in addition to phospholamban (PLB) in adult cardiomyocytes, explaining the differential ability of CNP (vs. BNP) to induce both lusitropic and negative inotropic responses. CNP stimulation in t-tubules and on the cell crest both increase cGMP near TnI and PLB similarly; PDE2 and PDE3 constrain cGMP in both compartments. In heart failure cardiomyocytes, CNP increases cGMP near PLB and TnI more than in sham cells.","method":"FRET-based targeted cGMP biosensors (PLB-targeted and TnI-targeted); scanning ion conductance microscopy (SICM) for local receptor stimulation; ventricular strip contractility measurements; PDE2/PDE3 inhibitor experiments; comparison of CNP vs. BNP in normal and heart failure rat cardiomyocytes","journal":"Cardiovascular Research","confidence":"High","confidence_rationale":"Tier 1 — novel FRET biosensors with subcellular resolution; multiple methods including SICM; mechanistic explanation of CNP vs. BNP differential effects","pmids":["33970224"],"is_preprint":false},{"year":2023,"finding":"CNP exerts antiarrhythmic effects via PDE2 (phosphodiesterase 2): CNP-stimulated cGMP activates PDE2, which hydrolyzes cAMP, reducing catecholamine-mediated arrhythmogenic events, ICaL, INaL, and Ca²⁺ spark frequency. PDE2 inhibition or cardiomyocyte-specific PDE2 deletion abolishes CNP's antiarrhythmic effect. These findings were confirmed in human iPSC-derived cardiomyocytes.","method":"Ex vivo perfused mouse hearts (arrhythmia after ischemia/reperfusion); in vivo catecholamine injection in mice; patch-clamp (ICaL, INaL); Ca²⁺ spark imaging; cAMP level measurement; protein phosphorylation (Western blot); cardiomyocyte-specific PDE2 knockout mice; pharmacological PDE2 inhibition; human iPSC-derived cardiomyocytes","journal":"Circulation Research","confidence":"High","confidence_rationale":"Tier 1-2 — genetic deletion plus pharmacological inhibition in multiple systems including human iPSC-CMs; mechanistic pathway fully dissected","pmids":["36715019"],"is_preprint":false},{"year":2024,"finding":"CNP promotes anti-inflammatory macrophage phenotype, efferocytosis, and reduces foam cell formation and necroptosis in atherosclerosis; mechanistically, CNP accelerates HIF-1α degradation by enhancing the interaction between PHD2 (prolyl hydroxylase domain-containing protein 2) and HIF-1α. CD36 binds CNP on the macrophage surface and mediates its endocytosis. CNP supplementation or overexpression reduces atherosclerotic plaque formation in ApoE-/- mice.","method":"Proteomics; co-immunoprecipitation (PHD2-HIF-1α interaction); CD36 knockout primary macrophages; endocytosis assay; CNP osmotic pump infusion and genetic overexpression in ApoE-/- mice; LCZ696 (neprilysin inhibitor) treatment; plaque analysis; macrophage functional assays (efferocytosis, foam cell formation, necroptosis)","journal":"Circulation Research","confidence":"High","confidence_rationale":"Tier 2 — Co-IP for molecular interaction plus CD36 KO macrophages for receptor identification; multiple mechanistic approaches; 38 citations","pmids":["38456298"],"is_preprint":false},{"year":1999,"finding":"Cloned ancestral shark NPR-B receptor activated by CNP increases cGMP (EC50 12 nM) and activates CFTR Cl⁻ channels (EC50 8 nM) when co-expressed in Xenopus oocytes with human CFTR, providing direct evidence that NPR-B/cGMP signaling activates CFTR; CNP increases oocyte cGMP 36-fold and Cl⁻ current 37-fold.","method":"Xenopus oocyte co-expression system; cGMP measurement; two-electrode voltage-clamp electrophysiology for Cl⁻ current measurement; receptor cloning and sequence analysis","journal":"American Journal of Physiology","confidence":"High","confidence_rationale":"Tier 1 — reconstitution in Xenopus oocytes with quantitative functional measurements","pmids":["9950772"],"is_preprint":false},{"year":1997,"finding":"CNP activates CFTR-dependent Cl⁻ transport in vivo in mouse nasal airway epithelium via membrane-bound guanylate cyclase activation; CNP effect is absent in CFTR-null mice and present in ΔF508 CFTR mice where CNP plus forskolin synergistically stimulates Cl⁻ secretion.","method":"In vivo nasal transepithelial potential difference (TEPD) assay in wild-type, CFTR-/-, and CFTR(ΔF/ΔF) mice; 8-Br-cGMP as positive control; pharmacological dissection","journal":"American Journal of Physiology","confidence":"High","confidence_rationale":"Tier 2 — in vivo genetic model (CFTR knockout) establishes CFTR-dependence of CNP effect","pmids":["9374736"],"is_preprint":false},{"year":1999,"finding":"NPR-C receptor activation by CNP (mimicked by selective NPR-C agonist cANF4-23) suppresses leukocyte rolling on venular endothelium and reduces P-selectin expression on endothelial cells, leukocytes, and platelets; CNP also inhibits thrombin-induced platelet aggregation. These anti-inflammatory effects are mediated at least in part through NPR-C-dependent suppression of P-selectin.","method":"Intravital microscopy of mouse mesenteric venules (eNOS-/- mice and IL-1β/histamine-induced inflammation); selective NPR-C agonist (cANF4-23) comparison; platelet aggregation assay of human blood; P-selectin expression analysis in HUVEC, leukocytes, and platelets","journal":"Proceedings of the National Academy of Sciences","confidence":"High","confidence_rationale":"Tier 2 — in vivo intravital microscopy with receptor-selective agonist; multiple cell types and functional assays; 83 citations","pmids":["16179391"],"is_preprint":false},{"year":2013,"finding":"2q37 deletions including the NPPC gene cause short stature with normal plasma CNP, while deletions that interrupt only the DIS3L2 gene (without involving NPPC) but are associated with elevated plasma CNP cause Marfanoid overgrowth, supporting that NPPC gene dosage directly determines CNP levels and skeletal growth outcome.","method":"Array CGH; NPPC gene copy number analysis; plasma CNP measurement by RIA; clinical phenotyping","journal":"PLOS ONE","confidence":"Medium","confidence_rationale":"Tier 2 — human genetics correlating gene dosage with CNP levels and opposite skeletal phenotypes; mechanistic inference from copy number/expression relationship","pmids":["23805197"],"is_preprint":false},{"year":2005,"finding":"CNP inhibits leukocyte-endothelial interactions and platelet activation via suppression of P-selectin expression; this effect is mediated through NPR-C (not NPR-B/cGMP), as selective NPR-C agonist cANF4-23 mimics CNP's effect.","method":"Intravital microscopy; selective receptor agonists; P-selectin expression assay in HUVEC and blood cells; platelet aggregometry","journal":"Proceedings of the National Academy of Sciences","confidence":"High","confidence_rationale":"Tier 2 — in vivo and in vitro assays with receptor-selective pharmacology; 83 citations","pmids":["16179391"],"is_preprint":false},{"year":2005,"finding":"CNP suppresses plasminogen activator inhibitor-1 (PAI-1) in vivo in a rabbit carotid artery collar model of intimal hyperplasia; both peri-arterial and intra-luminal CNP reduce PAI-1 in endothelium, adventitia, and neointima, and reduce macrophage infiltration, independently of superoxide.","method":"Rabbit carotid collar model; immunohistochemistry and densitometry for PAI-1; Western blot; peri-arterial and intra-luminal CNP delivery; superoxide chemiluminescence assay","journal":"Cardiovascular Research","confidence":"Medium","confidence_rationale":"Tier 2 — in vivo model with quantitative protein measurements; single laboratory","pmids":["15914122"],"is_preprint":false},{"year":2006,"finding":"CNP (but not ANP or BNP) relaxes human isolated subcutaneous resistance arteries via cGMP-dependent kinase (PKG) activation and opening of large-conductance Ca²⁺-activated potassium (BKCa) channels; this effect is endothelium-independent and not mediated by nitric oxide or soluble guanylate cyclase.","method":"Isometric myograph measurements on human subcutaneous resistance arteries; endothelium removal; NOS inhibition (L-NAME); soluble GC inhibitor (ODQ); PKG blocker (Rp-8-Br-cGMPS); high K⁺ and iberiotoxin (BKCa blocker); vasopeptidase inhibitor omapatrilat","journal":"Journal of the Renin-Angiotensin-Aldosterone System","confidence":"High","confidence_rationale":"Tier 1 — direct pharmacological dissection of signaling cascade in human tissue with multiple channel/kinase blockers","pmids":["17083062"],"is_preprint":false},{"year":2003,"finding":"CNP inhibits spontaneous contraction of guinea pig caecal circular smooth muscle cells via cGMP-dependent activation of calcium-activated potassium currents (IK(ca)), including spontaneous transient outward currents (STOCs); both soluble and particulate guanylate cyclase pathways contribute to CNP-induced relaxation.","method":"Smooth muscle strip contractility recording; whole-cell patch-clamp for IK(ca) and membrane potential; guanylate cyclase inhibitors (LY83583); cGMP phosphodiesterase inhibitor (zaparinast); TEA as non-selective K⁺ channel blocker","journal":"World Journal of Gastroenterology","confidence":"Medium","confidence_rationale":"Tier 1 — direct electrophysiology with pharmacological pathway dissection; single laboratory","pmids":["12970905"],"is_preprint":false},{"year":2017,"finding":"Bovine NPR2 is expressed not only in cumulus cells (as in mouse/porcine) but also in oocyte membranes; CNP can directly activate intra-oocyte cGMP production via NPR2 on the oocyte membrane in addition to the cumulus cell-mediated pathway, representing a species-specific mechanism. NPR2 expression in bovine CCs and oocytes is synergistically regulated by estradiol and oocyte-derived growth factors.","method":"Immunofluorescence localization of NPR2 in bovine COCs; cGMP measurement in isolated oocytes after CNP treatment; comparison with mouse and porcine; gene expression analysis","journal":"Theriogenology","confidence":"Medium","confidence_rationale":"Tier 2 — direct receptor localization and functional cGMP measurement in oocytes; single laboratory","pmids":["29080478"],"is_preprint":false},{"year":2014,"finding":"LH and amphiregulin (an EGF-like peptide acting via EGFR) decrease BNP and CNP (NPPC) production in porcine granulosa cells and downregulate NPR2 expression in cumulus cells, together reducing oocyte cGMP to permit meiotic resumption; the effect of AREG on natriuretic peptide signaling and oocyte maturation is completely blocked by EGFR kinase inhibitor AG1478, while LH effect is only partially reversed.","method":"Porcine granulosa cell culture; COC co-culture with granulosa cells; EGFR inhibitor (AG1478); RT-PCR and ELISA for NPPC/BNP and NPR2 expression; cGMP measurement; oocyte maturation assay","journal":"Molecular Reproduction and Development","confidence":"Medium","confidence_rationale":"Tier 2 — pharmacological dissection of LH→EGFR→CNP axis in porcine system; single laboratory","pmids":["25348585"],"is_preprint":false}],"current_model":"NPPC-encoded CNP is proteolytically processed from pro-CNP by furin, and acts as a paracrine/autocrine ligand that selectively binds and activates NPR-B (GC-B) guanylyl cyclase receptor to produce cGMP, with subordinate signaling via clearance receptor NPR-C; in bone, CNP/NPR-B signaling promotes endochondral ossification by inhibiting FGFR3-MAPK signaling in growth plate chondrocytes; in the ovary, mural granulosa cell-derived CNP maintains oocyte meiotic arrest via cumulus cell NPR2/cGMP until the LH surge triggers TTP-mediated Nppc mRNA degradation (via EGFR-ERK1/2) to decrease CNP and permit meiotic resumption; in the cardiovascular system, CNP regulates cardiomyocyte contractility by increasing cGMP near troponin I and phospholamban through NPR-B, exerts antiarrhythmic effects via PDE2 activation reducing cAMP, relaxes vascular smooth muscle via PKG-BKCa channels, and suppresses macrophage inflammation by enhancing PHD2-HIF-1α interaction (mediated by CD36-dependent endocytosis); CNP expression in endothelial cells is transcriptionally induced by hemodynamic shear stress through a calcium-dependent mechanism; and in the CNS, CNP acts as a bifurcation factor for sensory axons via NPR2-cGMP signaling."},"narrative":{"teleology":[{"year":1990,"claim":"Cloning of the NPPC gene and its brain-restricted expression established CNP as a distinct member of the natriuretic peptide family with a potential CNS role, answering whether natriuretic peptides existed beyond ANP and BNP.","evidence":"cDNA cloning, sequencing, and Northern blot in rat tissues showing brain-only expression; parallel human gene characterization with peptide identification by HPLC-RIA","pmids":["1702395","2018508"],"confidence":"High","gaps":["Full tissue distribution beyond brain not yet mapped","Receptor identity unknown"]},{"year":1991,"claim":"Demonstration that CNP selectively activates NPR-B (GC-B) rather than NPR-A resolved which receptor transduces CNP signals and defined the CNP–NPR-B–cGMP axis as the core signaling pathway.","evidence":"cGMP accumulation assays and binding competition in cells expressing recombinant human NPR-A vs. NPR-B; independent quantification of CNP's 50–500-fold selectivity","pmids":["1672777","1309330"],"confidence":"High","gaps":["No structural basis for receptor selectivity","Role of NPR-C clearance receptor in CNP signaling unclear"]},{"year":1996,"claim":"Discovery that CNP stimulates cGMP in osteoblasts and promotes differentiation markers linked CNP to skeletal biology, opening the question of whether CNP regulates bone growth in vivo.","evidence":"cGMP, DNA synthesis, alkaline phosphatase, osteocalcin, and mineralization assays in rat calvarial osteoblasts; 8-bromo-cGMP mimicry","pmids":["8967430"],"confidence":"High","gaps":["In vivo bone phenotype of CNP loss not yet established","Chondrocyte vs. osteoblast contributions unknown"]},{"year":1999,"claim":"Structural determination of the NPR-C–CNP complex revealed how a single CNP molecule induces asymmetric receptor closure, providing the first atomic-level view of natriuretic peptide receptor activation.","evidence":"X-ray crystallography at 2.0 Å resolution of NPR-C extracellular domain bound to CNP","pmids":["11533490"],"confidence":"High","gaps":["NPR-B structure with CNP not yet solved","Mechanism of intracellular guanylyl cyclase activation upon ligand binding unresolved"]},{"year":2003,"claim":"Identification of furin as the endoprotease processing pro-CNP to mature CNP resolved how the NPPC precursor is activated, distinguishing CNP processing from corin-dependent ANP maturation.","evidence":"Furin inhibitor blockade, furin-deficient cell reconstitution, purified furin cleavage, and bioactivity assay in HEK293/LoVo cells","pmids":["12736257"],"confidence":"High","gaps":["Whether other proprotein convertases contribute in specific tissues","Regulation of furin-mediated processing in vivo"]},{"year":2003,"claim":"Genetic rescue of achondroplasia-model mice by chondrocyte-specific CNP overexpression demonstrated that CNP opposes FGFR3-MAPK signaling in growth-plate chondrocytes, establishing the mechanistic basis for CNP's role in endochondral ossification.","evidence":"Transgenic CNP overexpression in FGFR3-activated mice; bone length measurement; pERK and STAT-1 Western blot","pmids":["14702637"],"confidence":"High","gaps":["Direct cGMP-to-MAPK inhibition intermediates not identified","Downstream effectors of MAPK inhibition in chondrocytes uncharacterized"]},{"year":2007,"claim":"Human chromosomal translocations separating NPPC from a negative regulatory element caused CNP overexpression and skeletal overgrowth, directly linking NPPC dosage to human growth regulation and providing the first human genetic evidence for NPPC gain-of-function.","evidence":"FISH, array-CGH, breakpoint cloning, plasma CNP by RIA, NPPC mRNA in patient fibroblasts, plus transgenic mouse phenocopying","pmids":["17373680","17676597"],"confidence":"High","gaps":["Identity of the distal negative regulatory element not determined","Whether NPPC copy number variation contributes to normal height variation"]},{"year":2008,"claim":"Characterization of the lbab hypomorphic Nppc mutation showed that a single conserved arginine in the CNP ring is critical for NPR-B binding, and chondrocyte-specific transgenic rescue proved the dwarfism is cartilage-autonomous.","evidence":"Radioligand competition binding, cGMP activation assays with mutant peptide, transgenic rescue, growth-plate histology","pmids":["18554750","18775416"],"confidence":"High","gaps":["Full structural basis for the arginine–NPR-B interaction","Whether heterozygous Nppc mutations cause milder skeletal phenotypes in mice"]},{"year":2010,"claim":"Discovery that mural granulosa cell–derived CNP maintains oocyte meiotic arrest via cumulus cell NPR2/cGMP established a new paracrine signaling axis essential for female fertility, answering how follicles prevent premature meiotic resumption.","evidence":"Nppc and Npr2 knockout mice with precocious meiotic resumption; in situ hybridization; in vitro cGMP rescue; oocyte-derived factor regulation of NPR2","pmids":["20947764"],"confidence":"High","gaps":["Mechanism of cGMP transfer from cumulus to oocyte not fully resolved","Identity of oocyte-derived factors regulating NPR2"]},{"year":2012,"claim":"Extension of the ovarian CNP model showed that amphiregulin (an EGFR ligand induced by LH) suppresses NPPC mRNA, defining the LH→EGFR→decreased NPPC→meiotic resumption pathway and explaining how the LH surge terminates CNP signaling.","evidence":"Amphiregulin treatment of granulosa cells; hCG in vivo; Npr2 mutant phenotyping at early antral stages; CNP analog therapeutic rescue in achondroplasia mice","pmids":["22987720","22696190","23200862"],"confidence":"High","gaps":["Post-transcriptional mechanism of NPPC mRNA decay not yet identified at this time","Whether BNP contributes redundantly in porcine systems"]},{"year":2013,"claim":"Demonstration that CNP modulates cardiomyocyte contractility via PKG-mediated phosphorylation of phospholamban and troponin I, dependent on SERCA2, established the molecular basis for CNP's negative inotropic and positive lusitropic cardiac effects.","evidence":"Muscle strip contractility, Ca²⁺ transient imaging, PLB/TnI phosphorylation Western blot, SERCA2 cardiomyocyte-specific knockout mice, PKG inhibitors","pmids":["23808942"],"confidence":"High","gaps":["Subcellular compartmentalization of CNP-stimulated cGMP not yet resolved","Relevance in human heart failure not yet tested"]},{"year":2017,"claim":"Identification of heterozygous loss-of-function NPPC mutations in patients with short stature provided the first direct human genetic evidence that NPPC haploinsufficiency causes growth impairment, completing the bidirectional dosage–phenotype relationship.","evidence":"NPPC sequencing in 668 patients, cGMP assay of mutant CNP peptides, family co-segregation","pmids":["28661490"],"confidence":"High","gaps":["Prevalence of NPPC mutations among all short stature patients unclear","Whether therapeutic CNP analog could rescue human NPPC haploinsufficiency"]},{"year":2021,"claim":"Identification of TTP (ZFP36) as the mediator of LH-induced Nppc mRNA degradation via a non-canonical AU-rich element resolved the post-transcriptional mechanism by which the LH surge terminates CNP production and permits oocyte meiotic resumption.","evidence":"MGC-specific Zfp36 conditional knockout; lentiviral knockdown; TTP–Nppc 3′ UTR RNA-binding assay; EGFR-ERK inhibitor pathway dissection; oocyte meiotic phenotyping","pmids":["34031239"],"confidence":"High","gaps":["Whether additional RNA-binding proteins contribute to Nppc mRNA regulation","Chromatin-level regulation of NPPC transcription during the LH surge"]},{"year":2022,"claim":"Subcellular FRET biosensor imaging revealed that CNP uniquely increases cGMP near both troponin I and phospholamban (unlike BNP), explaining the differential cardiac functional effects of NPR-B vs. NPR-A signaling and their modulation by PDE2/PDE3.","evidence":"Targeted cGMP FRET biosensors (PLB- and TnI-targeted); SICM local stimulation; PDE inhibitors; comparison of CNP vs. BNP in sham and heart failure cardiomyocytes","pmids":["33970224"],"confidence":"High","gaps":["Whether compartmentalized signaling differs in human vs. rodent cardiomyocytes","Role of NPR-B membrane localization in cGMP compartmentalization"]},{"year":2023,"claim":"Discovery that CNP's antiarrhythmic action operates through PDE2 activation (cGMP→PDE2→cAMP hydrolysis→reduced ICaL, INaL, and Ca²⁺ sparks) defined a cGMP-to-cAMP cross-talk mechanism confirmed by cardiomyocyte-specific PDE2 deletion and human iPSC-CMs.","evidence":"Ex vivo ischemia/reperfusion arrhythmia model; in vivo catecholamine challenge; patch-clamp; Ca²⁺ spark imaging; cardiomyocyte-specific PDE2 KO; human iPSC-CMs","pmids":["36715019"],"confidence":"High","gaps":["Whether chronic CNP supplementation provides sustained antiarrhythmic protection","Interaction between PDE2 and PDE3 pathways at therapeutic CNP doses"]},{"year":2024,"claim":"Identification of CD36 as a macrophage CNP receptor mediating endocytosis and the PHD2–HIF-1α degradation mechanism expanded CNP's role to anti-inflammatory and anti-atherogenic signaling independent of canonical NPR-B/cGMP.","evidence":"Co-IP for PHD2–HIF-1α interaction; CD36 KO macrophages; endocytosis assay; CNP infusion and genetic overexpression in ApoE⁻/⁻ mice; plaque quantification","pmids":["38456298"],"confidence":"High","gaps":["Whether CD36-mediated CNP signaling occurs in non-macrophage cell types","How intracellular CNP (post-endocytosis) physically enhances PHD2–HIF-1α binding","Independence from NPR-B or NPR-C requires further confirmation"]},{"year":null,"claim":"Key unresolved questions include the structural basis for CNP–NPR-B activation (no co-crystal structure), the identity of the distal negative regulatory element controlling NPPC transcription, the full spectrum of CNP's CNS functions beyond axon bifurcation, and whether CD36-mediated CNP signaling operates independently of canonical natriuretic peptide receptors in vivo.","evidence":"","pmids":[],"confidence":"High","gaps":["No NPR-B–CNP co-crystal structure available","Distal NPPC regulatory element not molecularly characterized","CNS functions beyond sensory axon bifurcation poorly defined"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0048018","term_label":"receptor ligand activity","supporting_discovery_ids":[0,4,5,19,27]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[15,16,22,34,35]}],"localization":[{"term_id":"GO:0005576","term_label":"extracellular region","supporting_discovery_ids":[2,7,17,24]}],"pathway":[{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[15,20,23,27,30]},{"term_id":"R-HSA-1474165","term_label":"Reproduction","supporting_discovery_ids":[22,24,26,32]},{"term_id":"R-HSA-112316","term_label":"Neuronal System","supporting_discovery_ids":[21]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[35,38,40]},{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[14]}],"complexes":[],"partners":["NPR2","NPR3","FURIN","FGFR3","CD36","PDE2A","ZFP36"],"other_free_text":[]},"mechanistic_narrative":"NPPC encodes C-type natriuretic peptide (CNP), a paracrine/autocrine signaling peptide that is proteolytically processed from a 126-amino acid precursor by furin and selectively activates the NPR-B (GC-B) guanylyl cyclase receptor to generate cGMP, with additional signaling through the clearance receptor NPR-C [PMID:1672777, PMID:12736257, PMID:1309330]. In bone, CNP/NPR-B/cGMP signaling is essential for endochondral ossification by promoting chondrocyte proliferation and hypertrophy and antagonizing FGFR3-MAPK signaling; loss-of-function NPPC mutations cause short stature in humans and mice, while gain-of-function (overexpression) produces skeletal overgrowth [PMID:14702637, PMID:28661490, PMID:17373680, PMID:20610569]. In the ovary, mural granulosa cell–derived CNP maintains oocyte meiotic arrest via cumulus cell NPR2/cGMP until the LH surge triggers EGFR–ERK1/2–dependent TTP-mediated degradation of Nppc mRNA, permitting meiotic resumption [PMID:20947764, PMID:34031239]. In the cardiovascular system, CNP modulates cardiomyocyte contractility through PKG-mediated phosphorylation of troponin I and phospholamban, exerts antiarrhythmic effects by PDE2-dependent cAMP hydrolysis, relaxes vascular smooth muscle via PKG–BKCa channels, and suppresses macrophage-driven inflammation by enhancing PHD2–HIF-1α interaction through CD36-mediated endocytosis [PMID:33970224, PMID:36715019, PMID:17083062, PMID:38456298]."},"prefetch_data":{"uniprot":{"accession":"P23582","full_name":"C-type natriuretic peptide","aliases":[],"length_aa":126,"mass_kda":13.2,"function":"Hormone which plays a role in endochondral ossification through regulation of cartilaginous growth plate chondrocytes proliferation and differentiation (By similarity). May also be vasoactive and natriuretic (PubMed:1672777). Acts by specifically binding and stimulating NPR2 to produce cGMP (PubMed:1672777, PubMed:21098034). Binds the clearance receptor NPR3 (PubMed:11533490)","subcellular_location":"Secreted","url":"https://www.uniprot.org/uniprotkb/P23582/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/NPPC","classification":"Not Classified","n_dependent_lines":8,"n_total_lines":1208,"dependency_fraction":0.006622516556291391},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"RAB29","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/NPPC","total_profiled":1310},"omim":[{"mim_id":"615923","title":"EPIPHYSEAL CHONDRODYSPLASIA, MIURA TYPE; ECDM","url":"https://www.omim.org/entry/615923"},{"mim_id":"613440","title":"STATURE QUANTITATIVE TRAIT LOCUS 21; STQTL21","url":"https://www.omim.org/entry/613440"},{"mim_id":"606255","title":"STATURE AS A QUANTITATIVE TRAIT","url":"https://www.omim.org/entry/606255"},{"mim_id":"604719","title":"SERINE/THREONINE PROTEIN KINASE 16; STK16","url":"https://www.omim.org/entry/604719"},{"mim_id":"600296","title":"NATRIURETIC PEPTIDE PRECURSOR C; NPPC","url":"https://www.omim.org/entry/600296"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"brain","ntpm":7.6}],"url":"https://www.proteinatlas.org/search/NPPC"},"hgnc":{"alias_symbol":["CNP"],"prev_symbol":[]},"alphafold":{"accession":"P23582","domains":[{"cath_id":"-","chopping":"3-98","consensus_level":"medium","plddt":63.9244,"start":3,"end":98}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P23582","model_url":"https://alphafold.ebi.ac.uk/files/AF-P23582-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P23582-F1-predicted_aligned_error_v6.png","plddt_mean":62.34},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=NPPC","jax_strain_url":"https://www.jax.org/strain/search?query=NPPC"},"sequence":{"accession":"P23582","fasta_url":"https://rest.uniprot.org/uniprotkb/P23582.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P23582/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P23582"}},"corpus_meta":[{"pmid":"1672777","id":"PMC_1672777","title":"Selective activation of the B natriuretic peptide receptor by C-type natriuretic peptide (CNP).","date":"1991","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/1672777","citation_count":731,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20947764","id":"PMC_20947764","title":"Granulosa cell ligand NPPC and its receptor NPR2 maintain meiotic arrest in mouse oocytes.","date":"2010","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/20947764","citation_count":454,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"14702637","id":"PMC_14702637","title":"Overexpression of CNP in chondrocytes rescues achondroplasia through a MAPK-dependent pathway.","date":"2003","source":"Nature medicine","url":"https://pubmed.ncbi.nlm.nih.gov/14702637","citation_count":303,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"1702395","id":"PMC_1702395","title":"Cloning and sequence analysis of a cDNA encoding a precursor for rat C-type natriuretic peptide (CNP).","date":"1990","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/1702395","citation_count":194,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23200862","id":"PMC_23200862","title":"Evaluation of the therapeutic potential of a CNP analog in a Fgfr3 mouse model recapitulating achondroplasia.","date":"2012","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/23200862","citation_count":153,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28076777","id":"PMC_28076777","title":"Antagonistic Functions of MBP and CNP Establish Cytosolic Channels in CNS Myelin.","date":"2017","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/28076777","citation_count":151,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16103231","id":"PMC_16103231","title":"Process outgrowth in oligodendrocytes is mediated by CNP, a novel microtubule assembly myelin protein.","date":"2005","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/16103231","citation_count":138,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"2164803","id":"PMC_2164803","title":"Novel natriuretic peptide, CNP, potently stimulates cyclic GMP production in rat cultured vascular smooth muscle cells.","date":"1990","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/2164803","citation_count":110,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17373680","id":"PMC_17373680","title":"Overexpression of the C-type natriuretic peptide (CNP) is associated with overgrowth and bone anomalies in an individual with balanced t(2;7) translocation.","date":"2007","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/17373680","citation_count":102,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8967430","id":"PMC_8967430","title":"cGMP produced in response to ANP and CNP regulates proliferation and differentiation of osteoblastic cells.","date":"1996","source":"The American journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/8967430","citation_count":98,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10739571","id":"PMC_10739571","title":"Myelin glycosphingolipid/cholesterol-enriched microdomains selectively sequester the non-compact myelin proteins CNP and MOG.","date":"1999","source":"Journal of neurocytology","url":"https://pubmed.ncbi.nlm.nih.gov/10739571","citation_count":88,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8462485","id":"PMC_8462485","title":"Detection of C-type natriuretic peptide (CNP) transcript in the rat heart and immune organs.","date":"1993","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/8462485","citation_count":80,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22987720","id":"PMC_22987720","title":"CNP/NPR2 signaling maintains oocyte meiotic arrest in early antral follicles and is suppressed by EGFR-mediated signaling in preovulatory follicles.","date":"2012","source":"Molecular reproduction and development","url":"https://pubmed.ncbi.nlm.nih.gov/22987720","citation_count":75,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"14749356","id":"PMC_14749356","title":"Inhibitory effect of C-type natriuretic peptide (CNP) on cultured cardiac myocyte hypertrophy: interference between CNP and endothelin-1 signaling pathways.","date":"2004","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/14749356","citation_count":74,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9373033","id":"PMC_9373033","title":"CNP overexpression induces aberrant oligodendrocyte membranes and inhibits MBP accumulation and myelin compaction.","date":"1997","source":"Journal of neuroscience research","url":"https://pubmed.ncbi.nlm.nih.gov/9373033","citation_count":72,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"7589445","id":"PMC_7589445","title":"Shear stress induces expression of CNP gene in human endothelial cells.","date":"1995","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/7589445","citation_count":68,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18756526","id":"PMC_18756526","title":"NG2 cell response in the CNP-EGFP mouse after contusive spinal cord injury.","date":"2009","source":"Glia","url":"https://pubmed.ncbi.nlm.nih.gov/18756526","citation_count":68,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9710259","id":"PMC_9710259","title":"Four-kilobase sequence of the mouse CNP gene directs spatial and temporal expression of lacZ in transgenic mice.","date":"1998","source":"Journal of neuroscience research","url":"https://pubmed.ncbi.nlm.nih.gov/9710259","citation_count":67,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17676597","id":"PMC_17676597","title":"A cluster of translocation breakpoints in 2q37 is associated with overexpression of NPPC in patients with a similar overgrowth phenotype.","date":"2007","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/17676597","citation_count":66,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26014585","id":"PMC_26014585","title":"The Local CNP/GC-B system in growth plate is responsible for physiological endochondral bone growth.","date":"2015","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/26014585","citation_count":64,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"7698765","id":"PMC_7698765","title":"Molecular cloning and chromosomal assignment of the mouse C-type natriuretic peptide (CNP) gene (Nppc): comparison with the human CNP gene (NPPC).","date":"1994","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/7698765","citation_count":63,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19805384","id":"PMC_19805384","title":"C-type natriuretic peptide (CNP) is a bifurcation factor for sensory neurons.","date":"2009","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/19805384","citation_count":62,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28661490","id":"PMC_28661490","title":"Mutations in C-natriuretic peptide (NPPC): a novel cause of autosomal dominant short stature.","date":"2017","source":"Genetics in medicine : official journal of the American College of Medical Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/28661490","citation_count":57,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"7988473","id":"PMC_7988473","title":"C-type natriuretic peptide (CNP) in the pituitary: is CNP an autocrine regulator of gonadotropes?","date":"1994","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/7988473","citation_count":54,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16205370","id":"PMC_16205370","title":"Expression of MBP, PLP, MAG, CNP, and GFAP in the Human Alcoholic Brain.","date":"2005","source":"Alcoholism, clinical and experimental research","url":"https://pubmed.ncbi.nlm.nih.gov/16205370","citation_count":50,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31235532","id":"PMC_31235532","title":"TransCon CNP, a Sustained-Release C-Type Natriuretic Peptide Prodrug, a Potentially Safe and Efficacious New Therapeutic Modality for the Treatment of Comorbidities Associated with Fibroblast Growth Factor Receptor 3-Related Skeletal Dysplasias.","date":"2019","source":"The Journal of pharmacology and experimental therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/31235532","citation_count":49,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33193424","id":"PMC_33193424","title":"Nanosilk Increases the Strength of Diabetic Skin and Delivers CNP-miR146a to Improve Wound Healing.","date":"2020","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/33193424","citation_count":46,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20567091","id":"PMC_20567091","title":"Translational research of C-type natriuretic peptide (CNP) into skeletal dysplasias.","date":"2010","source":"Endocrine journal","url":"https://pubmed.ncbi.nlm.nih.gov/20567091","citation_count":44,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22696190","id":"PMC_22696190","title":"NPPC/NPR2 signaling is essential for oocyte meiotic arrest and cumulus oophorus formation during follicular development in the mouse ovary.","date":"2012","source":"Reproduction (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/22696190","citation_count":43,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18094118","id":"PMC_18094118","title":"Mammalian 2',3' cyclic nucleotide phosphodiesterase (CNP) can function as a tRNA splicing enzyme in vivo.","date":"2007","source":"RNA (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/18094118","citation_count":43,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29080478","id":"PMC_29080478","title":"Natriuretic peptide receptor 2 (NPR2) localized in bovine oocyte underlies a unique mechanism for C-type natriuretic peptide (CNP)-induced meiotic arrest.","date":"2017","source":"Theriogenology","url":"https://pubmed.ncbi.nlm.nih.gov/29080478","citation_count":39,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"38456298","id":"PMC_38456298","title":"CNP Ameliorates Macrophage Inflammatory Response and Atherosclerosis.","date":"2024","source":"Circulation research","url":"https://pubmed.ncbi.nlm.nih.gov/38456298","citation_count":38,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25277077","id":"PMC_25277077","title":"In aging, the vulnerability of rat brain mitochondria is enhanced due to reduced level of 2',3'-cyclic nucleotide-3'-phosphodiesterase (CNP) and subsequently increased permeability transition in brain mitochondria in old animals.","date":"2014","source":"Neurochemistry international","url":"https://pubmed.ncbi.nlm.nih.gov/25277077","citation_count":38,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34538551","id":"PMC_34538551","title":"Mechanism of quercetin on the improvement of ovulation disorder and regulation of ovarian CNP/NPR2 in PCOS model rats.","date":"2021","source":"Journal of the Formosan Medical Association = Taiwan yi zhi","url":"https://pubmed.ncbi.nlm.nih.gov/34538551","citation_count":37,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31943851","id":"PMC_31943851","title":"Exosomal 2',3'-CNP from mesenchymal stem cells promotes hippocampus CA1 neurogenesis/neuritogenesis and contributes to rescue of cognition/learning deficiencies of damaged brain.","date":"2020","source":"Stem cells translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/31943851","citation_count":36,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27807896","id":"PMC_27807896","title":"Transient Cnp expression by early progenitors causes Cre-Lox-based reporter lines to map profoundly different fates.","date":"2016","source":"Glia","url":"https://pubmed.ncbi.nlm.nih.gov/27807896","citation_count":36,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17928074","id":"PMC_17928074","title":"ProCNP and CNP are expressed primarily in male genital organs.","date":"2007","source":"Regulatory peptides","url":"https://pubmed.ncbi.nlm.nih.gov/17928074","citation_count":35,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17336931","id":"PMC_17336931","title":"CNP infusion attenuates cardiac dysfunction and inflammation in myocarditis.","date":"2007","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/17336931","citation_count":35,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9950772","id":"PMC_9950772","title":"Cloning, characterization, and functional expression of a CNP receptor regulating CFTR in the shark rectal gland.","date":"1999","source":"The American journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/9950772","citation_count":34,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33187669","id":"PMC_33187669","title":"Characterization of a nitric oxide (NO) donor molecule and cerium oxide nanoparticle (CNP) interactions and their synergistic antimicrobial potential for biomedical applications.","date":"2020","source":"Journal of colloid and interface science","url":"https://pubmed.ncbi.nlm.nih.gov/33187669","citation_count":33,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33653372","id":"PMC_33653372","title":"Circ-AFF2/miR-650/CNP axis promotes proliferation, inflammatory response, migration, and invasion of rheumatoid arthritis synovial fibroblasts.","date":"2021","source":"Journal of orthopaedic surgery and research","url":"https://pubmed.ncbi.nlm.nih.gov/33653372","citation_count":32,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15072558","id":"PMC_15072558","title":"Four natriuretic peptides (ANP, BNP, VNP and CNP) coexist in the sturgeon: identification of BNP in fish lineage.","date":"2004","source":"Journal of molecular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/15072558","citation_count":32,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23805197","id":"PMC_23805197","title":"Genotype-Phenotype Correlation of 2q37 Deletions Including NPPC Gene Associated with Skeletal Malformations.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23805197","citation_count":30,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20437527","id":"PMC_20437527","title":"Cuprizone-induced demyelination in CNP::GFP transgenic mice.","date":"2010","source":"The Journal of comparative neurology","url":"https://pubmed.ncbi.nlm.nih.gov/20437527","citation_count":30,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12167597","id":"PMC_12167597","title":"CNP production in the kidney and effects of protein intake restriction in nephrotic syndrome.","date":"2002","source":"American journal of physiology. Renal physiology","url":"https://pubmed.ncbi.nlm.nih.gov/12167597","citation_count":29,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10468226","id":"PMC_10468226","title":"Shear stress induction of C-type natriuretic peptide (CNP) in endothelial cells is independent of NO autocrine signaling.","date":"1999","source":"Annals of biomedical engineering","url":"https://pubmed.ncbi.nlm.nih.gov/10468226","citation_count":29,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"7877717","id":"PMC_7877717","title":"Generation of a monoclonal antibody against the myelin protein CNP (2',3'-cyclic nucleotide 3'-phosphodiesterase) suitable for biochemical and for immunohistochemical investigations of CNP.","date":"1994","source":"Neurochemical research","url":"https://pubmed.ncbi.nlm.nih.gov/7877717","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31608492","id":"PMC_31608492","title":"Effects of Sprifermin, IGF1, IGF2, BMP7, or CNP on Bovine Chondrocytes in Monolayer and 3D Culture.","date":"2019","source":"Journal of orthopaedic research : official publication of the Orthopaedic Research Society","url":"https://pubmed.ncbi.nlm.nih.gov/31608492","citation_count":24,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15895405","id":"PMC_15895405","title":"Comparative analysis of the natriuretic peptide precursor gene cluster in vertebrates reveals loss of ANF and retention of CNP-3 in chicken.","date":"2005","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/15895405","citation_count":24,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10856898","id":"PMC_10856898","title":"C-type natriuretic peptide (CNP) effects in anterior pituitary cell lines: evidence for homologous desensitisation of CNP-stimulated cGMP accumulation in alpha T3-1 gonadotroph-derived cells.","date":"2000","source":"The Journal of endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/10856898","citation_count":24,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23808942","id":"PMC_23808942","title":"SERCA2 activity is involved in the CNP-mediated functional responses in failing rat myocardium.","date":"2013","source":"British journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/23808942","citation_count":24,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10510194","id":"PMC_10510194","title":"Action of C-type natriuretic peptide (CNP) on passive avoidance learning in rats: involvement of transmitters.","date":"1999","source":"The European journal of neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/10510194","citation_count":24,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18775416","id":"PMC_18775416","title":"Hypomorphic mutation in mouse Nppc gene causes retarded bone growth due to impaired endochondral ossification.","date":"2008","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/18775416","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25348585","id":"PMC_25348585","title":"Epidermal growth factor-network signaling mediates luteinizing hormone regulation of BNP and CNP and their receptor NPR2 during porcine oocyte meiotic resumption.","date":"2014","source":"Molecular reproduction and development","url":"https://pubmed.ncbi.nlm.nih.gov/25348585","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34031239","id":"PMC_34031239","title":"The mRNA-destabilizing protein Tristetraprolin targets \"meiosis arrester\" Nppc mRNA in mammalian preovulatory follicles.","date":"2021","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/34031239","citation_count":22,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17439653","id":"PMC_17439653","title":"A single nucleotide mutation in Nppc is associated with a long bone abnormality in lbab mice.","date":"2007","source":"BMC genetics","url":"https://pubmed.ncbi.nlm.nih.gov/17439653","citation_count":22,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33970224","id":"PMC_33970224","title":"CNP regulates cardiac contractility and increases cGMP near both SERCA and TnI: difference from BNP visualized by targeted cGMP biosensors.","date":"2022","source":"Cardiovascular research","url":"https://pubmed.ncbi.nlm.nih.gov/33970224","citation_count":22,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22954668","id":"PMC_22954668","title":"CNP and DPYSL2 mRNA expression and promoter methylation levels in brain of Alzheimer's disease patients.","date":"2013","source":"Journal of Alzheimer's disease : JAD","url":"https://pubmed.ncbi.nlm.nih.gov/22954668","citation_count":22,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34785225","id":"PMC_34785225","title":"Changes in soil total, microbial and enzymatic C-N-P contents and stoichiometry with depth and latitude in forest ecosystems.","date":"2021","source":"The Science of the total environment","url":"https://pubmed.ncbi.nlm.nih.gov/34785225","citation_count":21,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17083062","id":"PMC_17083062","title":"CNP, but not ANP or BNP, relax human isolated subcutaneous resistance arteries by an action involving cyclic GMP and BKCa channels.","date":"2006","source":"Journal of the renin-angiotensin-aldosterone system : JRAAS","url":"https://pubmed.ncbi.nlm.nih.gov/17083062","citation_count":21,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30176407","id":"PMC_30176407","title":"Biodegradation of 2,6-dibromo-4-nitrophenol by Cupriavidus sp. strain CNP-8: Kinetics, pathway, genetic and biochemical characterization.","date":"2018","source":"Journal of hazardous materials","url":"https://pubmed.ncbi.nlm.nih.gov/30176407","citation_count":21,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10834306","id":"PMC_10834306","title":"Effects of natriuretic peptides (ANP, BNP, CNP) on catecholamine synthesis and TH mRNA levels in PC12 cells.","date":"2000","source":"Life sciences","url":"https://pubmed.ncbi.nlm.nih.gov/10834306","citation_count":21,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12606274","id":"PMC_12606274","title":"Ambient salinity-dependent effects of homologous natriuretic peptides (ANP, VNP, and CNP) on plasma cortisol level in the eel.","date":"2003","source":"General and comparative endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/12606274","citation_count":21,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31951630","id":"PMC_31951630","title":"CNP mediated selective toxicity on melanoma cells is accompanied by mitochondrial dysfunction.","date":"2020","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/31951630","citation_count":21,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36101368","id":"PMC_36101368","title":"CNP, the Third Natriuretic Peptide: Its Biology and Significance to the Cardiovascular System.","date":"2022","source":"Biology","url":"https://pubmed.ncbi.nlm.nih.gov/36101368","citation_count":20,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10713220","id":"PMC_10713220","title":"Critical evaluation of p-nitrophenylphosphorylcholine (p-NPPC) as artificial substrate for the detection of phospholipase C*.","date":"2000","source":"Enzyme and microbial technology","url":"https://pubmed.ncbi.nlm.nih.gov/10713220","citation_count":20,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20610569","id":"PMC_20610569","title":"Circulating C-type natriuretic peptide (CNP) rescues chondrodysplastic CNP knockout mice from their impaired skeletal growth and early death.","date":"2010","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/20610569","citation_count":20,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32814248","id":"PMC_32814248","title":"Can extracellular vesicles from bovine ovarian follicular fluid modulate the in-vitro oocyte meiosis progression similarly to the CNP-NPR2 system?","date":"2020","source":"Theriogenology","url":"https://pubmed.ncbi.nlm.nih.gov/32814248","citation_count":20,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9374736","id":"PMC_9374736","title":"In vivo activation of CFTR-dependent chloride transport in murine airway epithelium by CNP.","date":"1997","source":"The American journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/9374736","citation_count":20,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"7706429","id":"PMC_7706429","title":"Co-expression of the natriuretic peptides (ANP, BNP, CNP) and their receptors in normal and acutely involuted rat thymus.","date":"1995","source":"Journal of neuroimmunology","url":"https://pubmed.ncbi.nlm.nih.gov/7706429","citation_count":20,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15198660","id":"PMC_15198660","title":"Presence of C-type natriuretic peptide (CNP) in guinea pig caecum: role and mechanisms of CNP in circular smooth muscle relaxation.","date":"2004","source":"Neurogastroenterology and motility","url":"https://pubmed.ncbi.nlm.nih.gov/15198660","citation_count":19,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31090455","id":"PMC_31090455","title":"Genetically induced brain inflammation by Cnp deletion transiently benefits from microglia depletion.","date":"2019","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/31090455","citation_count":19,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25663771","id":"PMC_25663771","title":"CNP signal pathway up-regulated in rectum of depressed rats and the interventional effect of Xiaoyaosan.","date":"2015","source":"World journal of gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/25663771","citation_count":18,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21262296","id":"PMC_21262296","title":"Central and peripheral forms of C-type natriuretic peptide (CNP): evidence for differential regulation in plasma and cerebrospinal fluid.","date":"2011","source":"Peptides","url":"https://pubmed.ncbi.nlm.nih.gov/21262296","citation_count":18,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8822517","id":"PMC_8822517","title":"Binding of CNP-22 and CNP-53 to cultured mouse astrocytes and effects on cyclic GMP.","date":"1996","source":"Peptides","url":"https://pubmed.ncbi.nlm.nih.gov/8822517","citation_count":18,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30355738","id":"PMC_30355738","title":"The cyclic phosphodiesterase CNP and RNA cyclase RtcA fine-tune noncanonical XBP1 splicing during ER stress.","date":"2018","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/30355738","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34838994","id":"PMC_34838994","title":"Lung function improves after delayed treatment with CNP-miR146a following acute lung injury.","date":"2021","source":"Nanomedicine : nanotechnology, biology, and medicine","url":"https://pubmed.ncbi.nlm.nih.gov/34838994","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35481707","id":"PMC_35481707","title":"Phase 1 safety, tolerability, pharmacokinetics and pharmacodynamics results of a long-acting C-type natriuretic peptide prodrug, TransCon CNP.","date":"2022","source":"British journal of clinical pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/35481707","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18554750","id":"PMC_18554750","title":"Reduced ability of C-type natriuretic peptide (CNP) to activate natriuretic peptide receptor B (NPR-B) causes dwarfism in lbab -/- mice.","date":"2008","source":"Peptides","url":"https://pubmed.ncbi.nlm.nih.gov/18554750","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"2580990","id":"PMC_2580990","title":"An immunochemical investigation of 2':3'-cyclic nucleotide 3'-phosphodiesterase (CNP) in bovine cerebrum and human oligodendroglioma.","date":"1985","source":"Journal of neuroscience research","url":"https://pubmed.ncbi.nlm.nih.gov/2580990","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29560541","id":"PMC_29560541","title":"Biodegradation of 2-chloro-4-nitrophenol via a hydroxyquinol pathway by a Gram-negative bacterium, Cupriavidus sp. strain CNP-8.","date":"2018","source":"AMB Express","url":"https://pubmed.ncbi.nlm.nih.gov/29560541","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28644737","id":"PMC_28644737","title":"Circulatory CNP Rescues Craniofacial Hypoplasia in Achondroplasia.","date":"2017","source":"Journal of dental research","url":"https://pubmed.ncbi.nlm.nih.gov/28644737","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37116556","id":"PMC_37116556","title":"CNP-miR146a improves outcomes in a two-hit acute- and ventilator-induced lung injury model.","date":"2023","source":"Nanomedicine : nanotechnology, biology, and medicine","url":"https://pubmed.ncbi.nlm.nih.gov/37116556","citation_count":16,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16979945","id":"PMC_16979945","title":"A novel peptide from the ACEI/BPP-CNP precursor in the venom of Crotalus durissus collilineatus.","date":"2006","source":"Comparative biochemistry and physiology. Toxicology & pharmacology : CBP","url":"https://pubmed.ncbi.nlm.nih.gov/16979945","citation_count":16,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24099862","id":"PMC_24099862","title":"Neutral endopeptidase (CD10) is abundantly expressed in the epididymis and localized to a distinct population of epithelial cells--its relevance for CNP degradation.","date":"2013","source":"Molecular and cellular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/24099862","citation_count":16,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9089468","id":"PMC_9089468","title":"Synthesis of C-type natriuretic peptide (CNP) by immortalized LHRH cells.","date":"1997","source":"Journal of neuroendocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/9089468","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10535407","id":"PMC_10535407","title":"C-type natriuretic peptide (CNP) effects on intracellular calcium [Ca2+]i in mouse gonadotrope-derived alphaT3-1 cell line.","date":"1999","source":"Regulatory peptides","url":"https://pubmed.ncbi.nlm.nih.gov/10535407","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36715019","id":"PMC_36715019","title":"CNP Promotes Antiarrhythmic Effects via Phosphodiesterase 2.","date":"2023","source":"Circulation research","url":"https://pubmed.ncbi.nlm.nih.gov/36715019","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12970905","id":"PMC_12970905","title":"Role of calcium-activated potassium currents in CNP-induced relaxation of gastric antral circular smooth muscle in guinea pigs.","date":"2003","source":"World journal of gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/12970905","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30114411","id":"PMC_30114411","title":"C-type natriuretic peptide (CNP) in endothelial cells attenuates hepatic fibrosis and inflammation in non-alcoholic steatohepatitis.","date":"2018","source":"Life sciences","url":"https://pubmed.ncbi.nlm.nih.gov/30114411","citation_count":14,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16740263","id":"PMC_16740263","title":"Identification of a natriuretic peptide (NP) in cyclostomes (lamprey and hagfish): CNP-4 is the ancestral gene of the NP family.","date":"2006","source":"General and comparative endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/16740263","citation_count":14,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15010203","id":"PMC_15010203","title":"Effect of C-type natriuretic peptide (CNP) on water channel aquaporin-4 (AQP4) expression in cultured astrocytes.","date":"2004","source":"Brain research. Molecular brain research","url":"https://pubmed.ncbi.nlm.nih.gov/15010203","citation_count":14,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8065530","id":"PMC_8065530","title":"In vivo phosphorylation of 2',3'-cyclic nucleotide 3'-phosphohydrolase (CNP): CNP in brain myelin is phosphorylated by forskolin- and phorbol ester-sensitive protein kinases.","date":"1994","source":"Neurochemical research","url":"https://pubmed.ncbi.nlm.nih.gov/8065530","citation_count":14,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36870619","id":"PMC_36870619","title":"Biochar amendments combined with organic fertilizer improve maize productivity and mitigate nutrient loss by regulating the C-N-P stoichiometry of soil, microbiome, and enzymes.","date":"2023","source":"Chemosphere","url":"https://pubmed.ncbi.nlm.nih.gov/36870619","citation_count":13,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9080425","id":"PMC_9080425","title":"Detection of C-type natriuretic peptide (CNP) and atrial natriuretic peptide (ANP-B) receptor mRNAs in rat inner ear.","date":"1997","source":"Neuroreport","url":"https://pubmed.ncbi.nlm.nih.gov/9080425","citation_count":13,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15914122","id":"PMC_15914122","title":"C-type natriuretic peptide (CNP) suppresses plasminogen activator inhibitor-1 (PAI-1) in vivo.","date":"2005","source":"Cardiovascular research","url":"https://pubmed.ncbi.nlm.nih.gov/15914122","citation_count":13,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8011177","id":"PMC_8011177","title":"The myelin protein CNP (2',3'-cyclic nucleotide 3'-phosphodiesterase): immunoaffinity purification of CNP from pig and rat brain using a monoclonal antibody and phosphorylation of CNP by cyclic nucleotide-dependent protein kinases.","date":"1994","source":"Biological chemistry Hoppe-Seyler","url":"https://pubmed.ncbi.nlm.nih.gov/8011177","citation_count":13,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35273320","id":"PMC_35273320","title":"Sequential IVM by CNP preincubation and cooperating of PGE2 with AREG enhances developmental competence of SCNT reconstructs in goat.","date":"2022","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/35273320","citation_count":12,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30672071","id":"PMC_30672071","title":"Electroacupuncture promotes the gastrointestinal motility of diabetic mice by CNP/NPR-B-cGMP and PDE3A-cGMP signaling.","date":"2019","source":"Neurogastroenterology and motility","url":"https://pubmed.ncbi.nlm.nih.gov/30672071","citation_count":12,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22300764","id":"PMC_22300764","title":"CNP-1 (ARRD-17), a novel substrate of calcineurin, is critical for modulation of egg-laying and locomotion in response to food and lysine sensation in Caenorhabditis elegans.","date":"2012","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/22300764","citation_count":12,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12477932","id":"PMC_12477932","title":"Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12477932","citation_count":1479,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"20881960","id":"PMC_20881960","title":"Hundreds of variants clustered in genomic loci and biological pathways affect human height.","date":"2010","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/20881960","citation_count":1451,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"1309330","id":"PMC_1309330","title":"Receptor selectivity of natriuretic peptide family, atrial natriuretic peptide, brain natriuretic peptide, and C-type natriuretic peptide.","date":"1992","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/1309330","citation_count":696,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21873635","id":"PMC_21873635","title":"Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.","date":"2011","source":"Briefings in bioinformatics","url":"https://pubmed.ncbi.nlm.nih.gov/21873635","citation_count":656,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"18391951","id":"PMC_18391951","title":"Many sequence variants affecting diversity of adult human height.","date":"2008","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/18391951","citation_count":520,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15489334","id":"PMC_15489334","title":"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).","date":"2004","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/15489334","citation_count":438,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"8353861","id":"PMC_8353861","title":"Natriuretic peptide system in human heart failure.","date":"1993","source":"Circulation","url":"https://pubmed.ncbi.nlm.nih.gov/8353861","citation_count":375,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"1855454","id":"PMC_1855454","title":"C-type natriuretic peptide (CNP) in rats and humans.","date":"1991","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/1855454","citation_count":310,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12736257","id":"PMC_12736257","title":"Furin-mediated processing of Pro-C-type natriuretic peptide.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12736257","citation_count":167,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19913121","id":"PMC_19913121","title":"Gene-centric association signals for lipids and apolipoproteins identified via the HumanCVD BeadChip.","date":"2009","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19913121","citation_count":164,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21296556","id":"PMC_21296556","title":"Current biochemistry, molecular biology, and clinical relevance of natriuretic peptides.","date":"2011","source":"Journal of cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/21296556","citation_count":148,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"11533490","id":"PMC_11533490","title":"Allosteric activation of a spring-loaded natriuretic peptide receptor dimer by hormone.","date":"2001","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/11533490","citation_count":146,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"1660465","id":"PMC_1660465","title":"Extracellular domain-IgG fusion proteins for three human natriuretic peptide receptors. Hormone pharmacology and application to solid phase screening of synthetic peptide antisera.","date":"1991","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/1660465","citation_count":125,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21865234","id":"PMC_21865234","title":"Pre-ovulatory LH/hCG surge decreases C-type natriuretic peptide secretion by ovarian granulosa cells to promote meiotic resumption of pre-ovulatory oocytes.","date":"2011","source":"Human reproduction (Oxford, England)","url":"https://pubmed.ncbi.nlm.nih.gov/21865234","citation_count":118,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"2018508","id":"PMC_2018508","title":"Gene and precursor structures of human C-type natriuretic peptide.","date":"1991","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/2018508","citation_count":115,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"31072047","id":"PMC_31072047","title":"C-type Natriuretic Peptide: A Multifaceted Paracrine Regulator in the Heart and Vasculature.","date":"2019","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/31072047","citation_count":100,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15911070","id":"PMC_15911070","title":"C-type natriuretic peptide and guanylyl cyclase B receptor.","date":"2005","source":"Peptides","url":"https://pubmed.ncbi.nlm.nih.gov/15911070","citation_count":86,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16179391","id":"PMC_16179391","title":"C-type natriuretic peptide inhibits leukocyte recruitment and platelet-leukocyte interactions via suppression of P-selectin expression.","date":"2005","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/16179391","citation_count":83,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19086053","id":"PMC_19086053","title":"Identification of new putative susceptibility genes for several psychiatric disorders by association analysis of regulatory and non-synonymous SNPs of 306 genes involved in neurotransmission and neurodevelopment.","date":"2009","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19086053","citation_count":81,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19620509","id":"PMC_19620509","title":"Regional release and clearance of C-type natriuretic peptides in the human circulation and relation to cardiac function.","date":"2009","source":"Hypertension (Dallas, Tex. : 1979)","url":"https://pubmed.ncbi.nlm.nih.gov/19620509","citation_count":81,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"25429064","id":"PMC_25429064","title":"Meta-analysis of genome-wide association studies of adult height in East Asians identifies 17 novel loci.","date":"2014","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/25429064","citation_count":77,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"1339402","id":"PMC_1339402","title":"Human C-type natriuretic peptide. Characterization of the gene and peptide.","date":"1992","source":"Hypertension (Dallas, Tex. : 1979)","url":"https://pubmed.ncbi.nlm.nih.gov/1339402","citation_count":75,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"17951249","id":"PMC_17951249","title":"Osteocrin is a specific ligand of the natriuretic Peptide clearance receptor that modulates bone growth.","date":"2007","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17951249","citation_count":73,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19570815","id":"PMC_19570815","title":"A genome-wide association study of northwestern Europeans involves the C-type natriuretic peptide signaling pathway in the etiology of human height variation.","date":"2009","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19570815","citation_count":71,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"8330189","id":"PMC_8330189","title":"C-type natriuretic peptide (CNP) is the major natriuretic peptide in human cerebrospinal fluid.","date":"1993","source":"Brain research","url":"https://pubmed.ncbi.nlm.nih.gov/8330189","citation_count":69,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"20966902","id":"PMC_20966902","title":"Genome-wide association study of anthropometric traits and evidence of interactions with age and study year in Filipino women.","date":"2010","source":"Obesity (Silver Spring, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/20966902","citation_count":68,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15815621","id":"PMC_15815621","title":"Generation and annotation of the DNA sequences of human chromosomes 2 and 4.","date":"2005","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/15815621","citation_count":66,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16006435","id":"PMC_16006435","title":"Amino-terminal proCNP: a putative marker of cartilage activity in postnatal growth.","date":"2005","source":"Pediatric research","url":"https://pubmed.ncbi.nlm.nih.gov/16006435","citation_count":60,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"20398908","id":"PMC_20398908","title":"Comprehensive copy number variant (CNV) analysis of neuronal pathways genes in psychiatric disorders identifies rare variants within patients.","date":"2010","source":"Journal of psychiatric research","url":"https://pubmed.ncbi.nlm.nih.gov/20398908","citation_count":59,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"29987050","id":"PMC_29987050","title":"Estrogen-regulated feedback loop limits the efficacy of estrogen receptor-targeted breast cancer therapy.","date":"2018","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/29987050","citation_count":59,"is_preprint":false,"source_track":"gene2pubmed"}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":51217,"output_tokens":7442,"usd":0.13264},"stage2":{"model":"claude-opus-4-6","input_tokens":11187,"output_tokens":4472,"usd":0.251603},"total_usd":0.858895,"stage1_batch_id":"msgbatch_012ZiiCUBfB62NCTQd4Bk1Jo","stage2_batch_id":"msgbatch_01Xuqq9aUHoQouS7UVGZNStZ","note":"batch pricing = 50% of standard","round2_stage1":{"model":"claude-sonnet-4-6","input_tokens":65580,"output_tokens":12785,"usd":0.194257},"round2_rules_fired":"R2","round2_stage2":{"model":"claude-opus-4-6","input_tokens":16486,"output_tokens":4180,"usd":0.280395}},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1991,\n      \"finding\": \"CNP (encoded by NPPC) selectively and potently activates the ANPR-B (NPR-B) guanylyl cyclase receptor, increasing cGMP, with 50- to 500-fold higher affinity for ANPR-B than ANP or BNP; CNP does not activate ANPR-A.\",\n      \"method\": \"Cell-based cGMP accumulation assay using cells expressing human ANPR-A or ANPR-B; receptor binding competition assays\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro receptor activation and binding assays with rigorous controls, highly cited foundational study\",\n      \"pmids\": [\"1672777\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1990,\n      \"finding\": \"CNP potently stimulates cGMP production and particulate guanylate cyclase activity in rat vascular smooth muscle cells (VSMC), with a 4-fold greater maximal activation than ANP, establishing CNP as a potent cGMP stimulator in VSMC distinct from its weak effect in renal glomeruli.\",\n      \"method\": \"In vitro cGMP measurement and particulate guanylate cyclase activity assay in cultured rat VSMC\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct enzymatic and cGMP accumulation assay in primary cells\",\n      \"pmids\": [\"2164803\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Mural granulosa cells express NPPC mRNA, while cumulus cells express NPR2; NPPC-derived CNP increases cGMP in cumulus cells and oocytes via NPR2 (a guanylyl cyclase), thereby maintaining meiotic arrest; Nppc or Npr2 mutant mice exhibit precocious meiotic resumption.\",\n      \"method\": \"In situ hybridization, in vitro cGMP assay, knockout mouse phenotyping (meiotic arrest assay), paracrine factor experiments\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal expression mapping, in vitro functional assay, and loss-of-function mouse models with defined meiotic phenotype; highly cited\",\n      \"pmids\": [\"20947764\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Targeted overexpression of CNP in chondrocytes rescues dwarfism in FGFR3-activated (achondroplasia) mice by inhibiting the MAPK pathway downstream of FGF signaling, correcting decreased extracellular matrix synthesis; CNP does not affect the STAT-1 pathway.\",\n      \"method\": \"Chondrocyte-specific transgenic overexpression of CNP; MAPK and STAT-1 pathway analysis; bone growth measurements\",\n      \"journal\": \"Nature medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis in mouse model with specific pathway dissection (MAPK vs. STAT-1), highly cited\",\n      \"pmids\": [\"14702637\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"A missense mutation (Arg→Gly) in the CNP ring of lbab mice reduces CNP binding to NPR-B by 10-fold and reduces receptor activation by 30- to >100-fold, establishing that reduced NPR-B activation by CNP causes dwarfism due to impaired endochondral ossification.\",\n      \"method\": \"Whole-cell cGMP elevation assay, membrane guanylyl cyclase assay, receptor binding competition with [125I]CNP, molecular modeling, transgenic rescue\",\n      \"journal\": \"Peptides / Biochemical and biophysical research communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — multiple in vitro assays (binding, enzyme activity) combined with in vivo transgenic rescue\",\n      \"pmids\": [\"18554750\", \"18775416\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"CNP/NPR2 signaling is essential for oocyte meiotic arrest in early antral follicles; LH surge suppresses NPPC mRNA in granulosa cells via the amphiregulin/EGFR pathway, thereby reducing cGMP and allowing meiotic resumption.\",\n      \"method\": \"Mutant mouse phenotyping (Npr2 mutation), granulosa cell culture with hCG/amphiregulin, qPCR of Nppc mRNA, EGF receptor inhibitor experiments\",\n      \"journal\": \"Molecular reproduction and development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — loss-of-function mouse model combined with in vitro pathway dissection\",\n      \"pmids\": [\"22987720\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Loss of NPPC/NPR2 signaling results in precocious meiotic resumption, oocyte degeneration, and absence of cumulus oophorus formation, establishing that this pathway is required for cumulus cell maintenance and oocyte developmental competence.\",\n      \"method\": \"Analysis of Nppc(lbab)/Nppc(lbab) and Npr2(cn)/Npr2(cn) mutant mice; histological examination; fertility testing\",\n      \"journal\": \"Reproduction\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — orthogonal loss-of-function mouse models with detailed phenotypic characterization\",\n      \"pmids\": [\"22696190\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"CNP, acting through its receptor NPR2 (particulate guanylyl cyclase), generates cGMP and is essential for sensory axon bifurcation at the dorsal root entry zone; CNP mutant mice show persistent bifurcation errors and reduced synaptic input to secondary neurons.\",\n      \"method\": \"CNP knockout mouse analysis, patch-clamp recordings of secondary neurons, axon tracing\",\n      \"journal\": \"PNAS\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — loss-of-function mouse with defined anatomical and electrophysiological phenotype\",\n      \"pmids\": [\"19805384\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"CNP inhibits ET-1-induced cardiac myocyte hypertrophy via a cGMP-dependent mechanism, reducing ERK phosphorylation, GATA-4/MEF-2 DNA binding, CaMKII activity, and intracellular Ca2+; conversely, ET-1 suppresses CNP-induced cGMP accumulation via protein kinase C and Ca2+-dependent mechanisms.\",\n      \"method\": \"Cultured cardiac myocyte hypertrophy assay; cGMP measurement; ERK phosphorylation; GATA-4/MEF-2 binding; CaMKII activity; 8-bromo-cGMP mimicry; PKC activator and Ca2+ ionophore experiments\",\n      \"journal\": \"Endocrinology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal biochemical assays in primary cells establishing bidirectional cross-talk\",\n      \"pmids\": [\"14749356\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"CNP increases cGMP near both SERCA/phospholamban (PLB) and troponin I (TnI) compartments in cardiomyocytes, causing phosphorylation of PLB Ser16 and TnI Ser23/24 via PKG, mediating both a negative inotropic response (NIR) and positive lusitropic response (LR) in failing hearts; both responses require SERCA2 activity.\",\n      \"method\": \"Muscle strip contractility, cGMP measurement, Ca2+ transient recording, protein phosphorylation assay, SERCA inhibitor (thapsigargin), PKG blocker, cardiomyocyte-specific SERCA2 knockout mice\",\n      \"journal\": \"British journal of pharmacology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (KO mice, inhibitors, phosphorylation assays) in primary cardiac cells\",\n      \"pmids\": [\"23808942\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"CNP (via NPR-B/GC-B) increases cGMP selectively near both PLB and TnI compartments in adult cardiomyocytes, whereas BNP (via NPR-A) increases cGMP only near PLB; this compartment-specific cGMP increase explains why CNP but not BNP produces lusitropic and negative inotropic responses; PDE2 and PDE3 constrain cGMP in both compartments.\",\n      \"method\": \"FRET-based subcellularly targeted cGMP biosensors (PLB- and TnI-targeted), scanning ion conductance microscopy combined with FRET, ventricular strip contractility assays\",\n      \"journal\": \"Cardiovascular research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — novel biosensor tools with direct subcellular cGMP measurement, corroborated by functional assays\",\n      \"pmids\": [\"33970224\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"CNP exerts antiarrhythmic effects by stimulating NPR-B to increase cGMP, which activates PDE2 to hydrolyze cAMP, thereby reducing ICaL, INaL, Ca2+ spark frequency, and phosphorylation of Ca2+-handling proteins; PDE2 inhibition or cardiomyocyte-specific PDE2 deletion abolishes CNP's antiarrhythmic effect.\",\n      \"method\": \"Ex vivo perfused mouse hearts (ischemia/reperfusion arrhythmia), in vivo catecholamine injection, patch-clamp (ICaL, INaL), Ca2+ spark imaging, cAMP/cGMP measurements, PDE2 pharmacological inhibition and cardiomyocyte-specific PDE2 knockout, human iPSC-derived cardiomyocytes\",\n      \"journal\": \"Circulation research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple model systems, genetic KO, and pharmacological validation with defined molecular mechanism\",\n      \"pmids\": [\"36715019\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"CNP is taken up by macrophages via CD36-mediated endocytosis; intracellular CNP enhances the PHD2-HIF-1α interaction, accelerating HIF-1α degradation, thereby suppressing macrophage inflammatory responses, reducing foam cell formation, and promoting efferocytosis and plaque stability.\",\n      \"method\": \"Proteomics, Co-IP (PHD2–HIF-1α interaction), CD36 KO macrophages, CNP supplementation in ApoE-/- mice, biochemical assays for HIF-1α degradation\",\n      \"journal\": \"Circulation research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — Co-IP for binding partner, KO validation, in vivo mouse model with mechanistic biochemical follow-up\",\n      \"pmids\": [\"38456298\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"LH surge induces tristetraprolin (TTP/ZFP36) in mural granulosa cells via the EGFR-ERK1/2 pathway; TTP binds to a noncanonical AU-rich element in the Nppc 3' UTR and promotes Nppc mRNA degradation, reducing CNP levels and permitting oocyte meiotic resumption.\",\n      \"method\": \"ZFP36 gain- and loss-of-function in vitro and in vivo (MGC-specific KO, lentiviral knockdown), RNA binding assays (ARE identification), qPCR, hCG challenge, ERK inhibitor experiments\",\n      \"journal\": \"PNAS\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic loss-of-function, RNA binding characterization, and in vivo knockdown with defined meiotic phenotype\",\n      \"pmids\": [\"34031239\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Cartilage-specific knockout of CNP or its receptor GC-B causes severe bone shortening equivalent to systemic knockout, demonstrating that the local CNP/GC-B system in the growth plate is responsible for physiological endochondral bone growth.\",\n      \"method\": \"Cartilage-specific Cre-mediated knockout of Nppc or GC-B; longitudinal bone measurement; histological analysis of growth plate zones\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — tissue-specific genetic KO with quantitative bone phenotyping\",\n      \"pmids\": [\"26014585\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"CNP stimulates cGMP production in osteoblast-like cells via NPR-B, leading to dose-dependent inhibition of DNA synthesis and stimulation of alkaline phosphatase activity, osteocalcin mRNA expression, and mineralization; these effects are reproduced by 8-bromo-cGMP.\",\n      \"method\": \"Primary osteoblast-like cell culture; cGMP measurement; DNA synthesis assay; alkaline phosphatase activity; osteocalcin mRNA; mineralization assay; 8-bromo-cGMP mimicry\",\n      \"journal\": \"American journal of physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — multiple functional assays in primary cells with second-messenger validation\",\n      \"pmids\": [\"8967430\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"CNP is produced by gonadotrope cells in the anterior pituitary; CNP acts on GC-B receptors expressed on gonadotropes to stimulate cGMP accumulation, suggesting an autocrine role; targeted toxicity experiments confirmed that CNP-producing cells are the same gonadotropes that express GC-B.\",\n      \"method\": \"Immunohistochemistry (CNP/LH co-localization), Northern blot for GC-B mRNA, RT-PCR, cGMP accumulation assay, GnRH-ricin A chain conjugate targeted toxicity\",\n      \"journal\": \"Endocrinology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods including targeted cellular ablation establishing autocrine production and receptor co-expression\",\n      \"pmids\": [\"7988473\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"Shear stress (24 dyne/cm2) markedly induces CNP mRNA expression in human endothelial cells within 3 h, maintained up to 12 h, identifying hemodynamic shear stress as a transcriptional regulator of NPPC.\",\n      \"method\": \"Cone-plate viscometer shear stress exposure of HUVECs; RT-PCR quantification of CNP mRNA\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — single experimental method (RT-PCR) in cultured cells, but clear mechanistic link\",\n      \"pmids\": [\"7589445\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Shear stress induction of CNP mRNA in endothelial cells is independent of NO autocrine signaling and tyrosine kinase activity, but requires intracellular calcium (blocked by BAPTA/AM); arterial-level shear is more potent than venous-level shear.\",\n      \"method\": \"Shear stress assay with L-NAME (NOS inhibitor), genistein (tyrosine kinase inhibitor), BAPTA/AM (Ca2+ chelator); RT-PCR; CNP secretion ELISA\",\n      \"journal\": \"Annals of biomedical engineering\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — pharmacological pathway dissection in primary endothelial cells\",\n      \"pmids\": [\"10468226\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"CNP protein in brain myelin is phosphorylated in vivo on serine (94%) and threonine (5%) residues; CNP2 is phosphorylated by protein kinase A (cAMP-dependent, 6-fold increase) and PKC (phorbol ester-sensitive, 2-fold increase) at distinct sites; CNP2 is more heavily phosphorylated than CNP1.\",\n      \"method\": \"In vivo 32P labeling of brain slices, phosphoamino acid analysis, immunoprecipitation, PKA incubation with [γ-32P]ATP, phorbol ester treatment\",\n      \"journal\": \"Neurochemical research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct in vivo and cell-free phosphorylation assays with kinase identification\",\n      \"pmids\": [\"8065530\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"Purified porcine CNP (both 44.6 and 45.9 kDa isoforms) is rapidly and specifically phosphorylated in vitro by protein kinase A and cGMP-dependent protein kinase.\",\n      \"method\": \"Immunoaffinity purification of CNP; in vitro phosphorylation by PKA and PKG\",\n      \"journal\": \"Biological chemistry Hoppe-Seyler\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 — direct in vitro phosphorylation assay with purified protein\",\n      \"pmids\": [\"8011177\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"CNP activates CFTR-dependent Cl- transport in mouse nasal epithelium in vivo via membrane-bound guanylate cyclase stimulation; this effect requires functional CFTR (absent in CFTR-/- mice) and is synergistic with cAMP pathway activation in ΔF508 CFTR mice.\",\n      \"method\": \"In vivo nasal transepithelial potential difference assay in wild-type, CFTR-ΔF508, and CFTR-/- mice; 8-bromo-cGMP comparison; forskolin combination\",\n      \"journal\": \"American journal of physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo genetic model with defined CFTR-dependent readout\",\n      \"pmids\": [\"9374736\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"A cloned shark NPR-B receptor, when co-expressed with human CFTR in Xenopus oocytes, activates CFTR Cl- channels upon CNP stimulation (EC50 ~8 nM), with 36-fold cGMP increase and 37-fold Cl- current increase, establishing the CNP-NPR-B-cGMP-CFTR signaling axis.\",\n      \"method\": \"cDNA cloning; heterologous expression in Xenopus oocytes; two-electrode voltage clamp; cGMP measurement\",\n      \"journal\": \"American journal of physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstitution in Xenopus oocytes with defined pharmacological parameters\",\n      \"pmids\": [\"9950772\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"CNP (but not ANP or BNP) relaxes human isolated subcutaneous resistance arteries via cGMP-dependent kinase activation and opening of BKCa (large-conductance Ca2+-activated K+) channels; the effect is endothelium-independent and enhanced by vasopeptidase inhibition.\",\n      \"method\": \"Isometric myograph on human resistance arteries; endothelium removal; pharmacological inhibitors (Rp-8-Br-cGMPS, iberiotoxin, high K+, omapatrilat); cGMP pathway analysis\",\n      \"journal\": \"Journal of the renin-angiotensin-aldosterone system\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct vascular functional assay with pharmacological pathway dissection in human tissue\",\n      \"pmids\": [\"17083062\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Two heterozygous missense mutations in the conserved CNP ring (NPPC) identified in short stature patients show significantly reduced cGMP synthesis when tested functionally, establishing NPPC mutations as a cause of autosomal dominant short stature in humans.\",\n      \"method\": \"Whole-exome sequencing; cGMP synthesis functional assay for mutant CNP peptides; segregation analysis\",\n      \"journal\": \"Genetics in medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — direct functional assay of mutant peptides combined with human genetic evidence\",\n      \"pmids\": [\"28661490\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"The mammalian CNP enzyme (2',3'-cyclic nucleotide 3'-phosphodiesterase) suppresses RtcB-mediated XBP1 splicing during ER stress by hydrolyzing the 2',3'-cyclic phosphate on cleaved exon termini, converting it to 2'-phosphate; RtcA (RNA 3'-terminal cyclase) counteracts CNP by regenerating 2',3'-cyclic phosphate.\",\n      \"method\": \"In vitro XBP1 splicing assay; mouse and human cell lines; RtcB-KO cells; pharmacological manipulation; epistasis between CNP, RtcA, and RtcB\",\n      \"journal\": \"Journal of Biological Chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro biochemical reconstitution with genetic epistasis in cell lines\",\n      \"pmids\": [\"30355738\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Mammalian CNP can perform the 3' end-healing step of tRNA splicing in vivo (yeast complementation), hydrolyzing 2',3'-cyclic phosphate at tRNA exon termini, but CNP is not essential for tRNA splicing in mice.\",\n      \"method\": \"Yeast complementation of tRNA ligase healing-domain mutants; growth assays; mouse genetics\",\n      \"journal\": \"RNA\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vivo functional complementation establishing biochemical activity\",\n      \"pmids\": [\"18094118\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Systemic (circulating) CNP delivered via liver-specific transgene rescues impaired endochondral bone growth and reduces mortality of CNP knockout mice, demonstrating that CNP can act as an endocrine (humoral) factor in addition to its paracrine/autocrine role in bone growth.\",\n      \"method\": \"SAP-Nppc-Tg transgenic mice crossed with CNP knockout mice; organ culture tibial explants; longitudinal bone measurement; survival analysis\",\n      \"journal\": \"Endocrinology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic rescue experiment with organ culture controls\",\n      \"pmids\": [\"20610569\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"NEP (neprilysin/CD10) is highly expressed in epididymal epithelium and degrades CNP; NEP inhibition decreases CNP degradation and increases CNP/GC-B-induced cGMP production in epididymal membranes, establishing NEP as a key regulator of local CNP bioavailability in the epididymis.\",\n      \"method\": \"NEP protein quantification across organs; immunolocalization; cGMP production assay with NEP inhibitors in epididymal membranes\",\n      \"journal\": \"Molecular and cellular endocrinology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — functional assay with pharmacological inhibitors in native tissue\",\n      \"pmids\": [\"24099862\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"CNP and its receptor NPR2 localize in bovine cumulus cells and, uniquely, also in oocyte membranes; CNP can directly activate intra-oocyte cGMP production via NPR2 on oocyte membranes in parallel to the cumulus cell-mediated pathway.\",\n      \"method\": \"Immunofluorescence localization of NPR2; intracellular cGMP measurement in isolated oocytes; NPR2 function in oocyte vs. cumulus cells\",\n      \"journal\": \"Theriogenology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — localization plus functional cGMP assay, single study in bovine model\",\n      \"pmids\": [\"29080478\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"LH and EGF-like peptide amphiregulin (via EGFR) decrease BNP and CNP production in porcine granulosa cells and downregulate NPR2 expression in cumulus cells, together reducing oocyte cGMP and permitting meiotic resumption; EGFR kinase inhibitor (AG1478) blocks the AREG effect but only partially reverses LH action.\",\n      \"method\": \"Porcine COC culture with LH, AREG, AG1478; granulosa cell CNP/BNP measurement; cumulus cell NPR2 expression; oocyte cGMP measurement; oocyte maturation assay\",\n      \"journal\": \"Molecular reproduction and development\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — pharmacological pathway dissection in primary porcine cells\",\n      \"pmids\": [\"25348585\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"CNP inhibits spontaneous contraction of guinea pig caecal circular smooth muscle in a cGMP-dependent manner via both particulate and soluble guanylate cyclase systems, acting through NPR-B and NPR-C; CNP hyperpolarizes smooth muscle cells and increases calcium-activated potassium currents (IK(ca)) and STOCs.\",\n      \"method\": \"Smooth muscle strip contractility; guanylate cyclase inhibitor (Ly83583); phosphodiesterase inhibitor (Zaparinast); whole-cell patch-clamp; membrane potential measurement; TEA blockade\",\n      \"journal\": \"Neurogastroenterology and motility\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1–2 — multiple functional and electrophysiological assays in native tissue\",\n      \"pmids\": [\"15198660\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"NPPC encodes C-type natriuretic peptide (CNP), a secreted peptide that selectively activates the NPR-B (GC-B) receptor guanylyl cyclase to generate cGMP, mediating diverse tissue-specific actions including maintenance of oocyte meiotic arrest (via granulosa-cell-to-cumulus-cell paracrine CNP→NPR2→cGMP signaling), stimulation of endochondral bone growth (by antagonizing FGFR3-MAPK signaling in chondrocytes), cardiac contractility modulation (through compartment-specific cGMP elevation near PLB and TnI), antiarrhythmic effects (via cGMP-stimulated PDE2-mediated cAMP hydrolysis), vascular smooth muscle relaxation (through PKG and BKCa channel activation), and regulation of RNA metabolism (by hydrolyzing 2',3'-cyclic phosphate termini on RNA substrates including XBP1 during ER stress); NPPC mRNA is regulated post-transcriptionally by the mRNA-destabilizing protein TTP and transcriptionally by hemodynamic shear stress, while CNP protein bioavailability is controlled by neprilysin-mediated degradation.\"\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\nI'll systematically classify each paper before extracting discoveries.\n\n**Classification:**\n\nThe target gene is NPPC (natriuretic peptide precursor C), encoding C-type natriuretic peptide (CNP-22/CNP-53), the ligand for NPR-B/GC-B.\n\nPapers to EXCLUDE (alias collisions):\n- Papers about 2',3'-cyclic nucleotide 3'-phosphodiesterase (CNP/CNPase) — a completely different protein (myelin enzyme) that shares the abbreviation \"CNP\": Papers [6,7,11,15,17,18,25,30,33,34,35,36,41,44,47,58,72,76,80,93,97] from main corpus\n- Papers about cerium oxide nanoparticles (CNP): [27,40,64,77,83]\n- Papers about Cupriavidus sp. strain CNP-8 (bacterial): [61,81]\n- Papers about C-N-P stoichiometry in soil: [59,94]\n- C. elegans CNP-1/calcineurin substrate: [100]\n- p-NPPC (artificial substrate for phospholipase C): [66]\n- Papers purely about GWAS/height association with no mechanistic content: [additional corpus papers 2,5,21,24,26,29]\n- MGC cDNA library papers: [additional 1,6]\n- GO annotation paper: [additional 4]\n- Chromosome sequencing: [additional 27]\n- Psychiatric CNV: [additional 29]\n- Breast cancer CSK/PAK2: [additional 30]\n- Lipid GWAS: [additional 10]\n- Psychiatric SNP association: [additional 19]\n\nPapers to KEEP (about NPPC/CNP natriuretic peptide):\nMain corpus: [1,2,3,4,5,8,9,10,12,13,14,16,19,20,21,22,23,24,26,28,29,31,32,37,38,39,42,43,45,46,48,49,50,51,52,53,54,55,56,57,60,62,63,65,67,68,69,70,71,73,74,75,78,79,82,84,85,86,87,88,89,90,91,92,95,96,98,99]\n\nAdditional corpus: [3,7,8,9,11,12,13,14,15,16,17,18,20,22,23,25,28]\n\n```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1991,\n      \"finding\": \"CNP (encoded by NPPC) selectively and potently activates the ANPR-B (NPR-B/GC-B) guanylyl cyclase receptor, with 50- to 500-fold higher affinity for NPR-B than ANP or BNP respectively, and does not stimulate cGMP accumulation via ANPR-A (NPR-A/GC-A).\",\n      \"method\": \"Cell-based cGMP accumulation assay and receptor binding competition in cells expressing recombinant human ANPR-A or ANPR-B\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct receptor activation assay with quantified binding affinities; foundational paper with 731 citations, replicated across multiple subsequent studies\",\n      \"pmids\": [\"1672777\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1991,\n      \"finding\": \"Human NPPC encodes a 126-amino acid prepro-CNP precursor processed to yield CNP-22 and CNP-53; the gene contains at least two exons and one intron, with a 5'-flanking region containing an inverted CCAAT box, two GC boxes, and a cAMP response element-like sequence distinct from ANP and BNP gene promoters.\",\n      \"method\": \"Genomic library cloning, sequencing, and cDNA structure analysis; HPLC-RIA for peptide identification in human brain\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct gene/protein characterization with sequencing and peptide identification\",\n      \"pmids\": [\"2018508\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1991,\n      \"finding\": \"CNP-like immunoreactivity is highest in the anterior pituitary and present throughout the brain, with tissue distribution and processing pattern (yielding CNP and CNP-53) clearly different from ANP and BNP, consistent with a role as a neuropeptide/neuromodulator rather than a cardiac hormone.\",\n      \"method\": \"Specific radioimmunoassay (RIA) for CNP, HPLC-gel permeation chromatography to resolve molecular forms in rat and human tissues\",\n      \"journal\": \"Endocrinology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal biochemical methods (RIA + HPLC) across multiple tissues; foundational tissue distribution paper\",\n      \"pmids\": [\"1855454\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1990,\n      \"finding\": \"Rat NPPC encodes a 126-residue precursor with a 23-residue signal sequence; CNP mRNA is expressed exclusively in the brain (by Northern blot), suggesting CNP functions as a CNS neuropeptide.\",\n      \"method\": \"cDNA library cloning, sequencing, RNA blot hybridization\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct molecular cloning and sequence determination with expression analysis\",\n      \"pmids\": [\"1702395\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1990,\n      \"finding\": \"CNP potently increases cGMP levels and stimulates guanylate cyclase activity in the particulate fraction of rat vascular smooth muscle cells (VSMC), with maximum activation 4-fold higher than ANP, establishing CNP as a potent cGMP stimulator specifically in VSMC.\",\n      \"method\": \"Cell-based cGMP measurement, guanylate cyclase activity assay in particulate fraction of cultured rat VSMC\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct enzymatic assay in relevant primary cells; highly cited foundational study\",\n      \"pmids\": [\"2164803\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1992,\n      \"finding\": \"CNP binds with highest affinity to NPR-B (GC-B) and activates cGMP production via NPR-B with rank order CNP > ANP ≥ BNP; CNP binds NPR-C clearance receptor with intermediate affinity (ANP > CNP > BNP); species differences exist in receptor selectivity, particularly for BNP.\",\n      \"method\": \"Radioligand binding competition assays and cGMP production assays using receptor preparations from human, bovine, and rat tissues and cultured cells; Northern blot for receptor expression\",\n      \"journal\": \"Endocrinology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — comprehensive binding and functional assays across species; 696 citations\",\n      \"pmids\": [\"1309330\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1992,\n      \"finding\": \"Human NPPC gene is located on chromosome 2 (later refined to 2q37.1) and encodes a 126-amino acid prepro-CNP; the 5'-flanking region contains cis-regulatory elements (inverted CCAAT box, GC boxes, cAMP response element-like sequence) absent in ANP and BNP gene promoters. CNP is the dominant natriuretic peptide in human brain.\",\n      \"method\": \"Genomic cloning, sequencing, somatic hybrid cell chromosome mapping, HPLC-RIA for peptide identification in human brain\",\n      \"journal\": \"Hypertension\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct gene characterization with chromosomal mapping and peptide identification\",\n      \"pmids\": [\"1339402\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"CNP is the major natriuretic peptide in human cerebrospinal fluid (CSF), present at ~10-fold higher concentration than ANP or BNP in CSF, while CNP is undetectable in plasma, supporting a primary CNS paracrine/autocrine role for NPPC-derived CNP.\",\n      \"method\": \"Specific radioimmunoassay (RIA) measurement of ANP, BNP, and CNP in matched CSF and plasma samples from patients\",\n      \"journal\": \"Brain research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct quantitative measurement establishing compartmentalization of CNP expression\",\n      \"pmids\": [\"8330189\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"Mouse NPPC (Nppc) gene maps to chromosome 1, is composed of at least two exons and one intron, with conserved 5'-flanking regulatory elements; comparison with human NPPC reveals conserved and divergent regions. Human NPPC maps to chromosome 2.\",\n      \"method\": \"Genomic library cloning, sequencing, PCR-based microsatellite polymorphism analysis in recombinant inbred mouse strains, somatic hybrid cell chromosome mapping\",\n      \"journal\": \"Genomics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct molecular characterization and chromosomal mapping\",\n      \"pmids\": [\"7698765\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"CNP is produced in the anterior pituitary predominantly by gonadotropes (co-localized with LH); pituitary cells express GC-B (NPR-B) but not GC-A; CNP potently stimulates cGMP in gonadotropes, suggesting an autocrine role. Selective destruction of gonadotropes reduced both CNP-stimulated cGMP production and GnRH-stimulated LH release.\",\n      \"method\": \"RT-PCR for CNP precursor mRNA, immunohistochemistry with co-localization of CNP and LH, targeted toxin (GnRH-ricin A conjugate) to selectively ablate gonadotropes, cGMP accumulation assay\",\n      \"journal\": \"Endocrinology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods including cell-type specific ablation with functional readout\",\n      \"pmids\": [\"7988473\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"CNP stimulates cGMP production in osteoblast-like cells via NPR-B, inhibits DNA synthesis in a dose-dependent manner, and promotes osteoblast differentiation markers (alkaline phosphatase activity, osteocalcin mRNA, mineralization); these effects are mimicked by 8-bromo-cGMP, establishing a cGMP-mediated signaling pathway for CNP in bone formation. CNP-like immunoreactivity is detected in conditioned medium from osteoblasts.\",\n      \"method\": \"cGMP accumulation assay, DNA synthesis (thymidine incorporation), alkaline phosphatase activity assay, Northern blot for gene expression, mineralization nodule quantification in cultured rat calvarial osteoblasts\",\n      \"journal\": \"American journal of physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple functional assays with cGMP analog confirmation of mechanism\",\n      \"pmids\": [\"8967430\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"Shear stress (24 dyne/cm²) markedly induces NPPC mRNA expression in human umbilical vein endothelial cells within 3 hours, maintained through 12 hours, identifying hemodynamic flow as a transcriptional regulator of CNP gene expression.\",\n      \"method\": \"Cone-plate viscometer shear stress exposure of HUVEC; CNP mRNA quantification by RT-PCR\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct experimental manipulation with molecular readout; single lab study\",\n      \"pmids\": [\"7589445\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Shear stress induction of NPPC mRNA in endothelial cells is independent of NO autocrine signaling (not blocked by L-NAME or genistein) but is attenuated 71% by intracellular calcium chelation (BAPTA/AM), implicating calcium-dependent signaling in flow-mediated CNP transcriptional regulation. Dexamethasone potentiates shear-stress-induced CNP mRNA 2-fold.\",\n      \"method\": \"Defined laminar shear stress (25 dyn/cm²) of bovine aortic endothelial cells; PhosphorImager quantification of CNP/GAPDH mRNA ratio; pharmacological inhibition of NO synthase, tyrosine kinase, calcium signaling; CNP secretion measurement by RIA\",\n      \"journal\": \"Annals of biomedical engineering\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple pharmacological probes dissecting signaling pathway; single lab\",\n      \"pmids\": [\"10468226\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Crystal structure of NPR-C extracellular domain bound to CNP reveals that a single CNP molecule binds asymmetrically at the interface of a symmetric NPR-C dimer, inducing a 20 Å closure between membrane-proximal domains; each monomer contains a molecular spring (linker peptide) that is an allosteric trigger for intracellular signaling.\",\n      \"method\": \"X-ray crystallography at 2.9 Å (unliganded) and 2.0 Å (CNP-bound) resolution; hormone-binding thermodynamics\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — high-resolution crystal structures with functional thermodynamic validation\",\n      \"pmids\": [\"11533490\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Furin is the critical intracellular endoprotease responsible for processing pro-CNP to mature CNP. Pro-CNP processing is blocked by furin inhibitors, absent in furin-deficient LoVo cells, and restored by recombinant furin expression; corin (the ANP convertase) does not process pro-CNP. Furin-processed CNP is biologically active in cGMP assays.\",\n      \"method\": \"Recombinant expression in HEK293 and SW1353 cells; furin inhibitor treatment; expression in furin-deficient LoVo cells with reconstitution; incubation with purified recombinant furin; Western blot; cell-based cGMP bioassay\",\n      \"journal\": \"Journal of Biological Chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstitution experiment with purified enzyme plus loss-of-function/gain-of-function in multiple cell lines; 167 citations\",\n      \"pmids\": [\"12736257\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"CNP overexpression in chondrocytes rescues dwarfism in achondroplasia mice (activated FGFR3) by correcting decreased extracellular matrix synthesis in the growth plate through inhibition of the MAPK pathway of FGF signaling; CNP does not affect the STAT-1 pathway of FGFR3 signaling.\",\n      \"method\": \"Transgenic chondrocyte-specific CNP overexpression in FGFR3-activated achondroplasia mouse model; bone length measurement; immunohistochemistry; Western blot for phospho-ERK (MAPK) and STAT-1 pathway markers\",\n      \"journal\": \"Nature Medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic rescue experiment with pathway-specific pharmacological/molecular dissection; 303 citations\",\n      \"pmids\": [\"14702637\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"CNP inhibits endothelin-1 (ET-1)-induced cardiac myocyte hypertrophy via a cGMP-dependent mechanism, suppressing protein synthesis, ANP secretion, GATA-4/MEF-2 DNA binding, CaM kinase II activity, ERK phosphorylation, and intracellular Ca²⁺ increase. Conversely, ET-1 suppresses CNP-induced cGMP accumulation through a protein kinase C- and Ca²⁺-dependent mechanism, establishing mutual interference between CNP and ET-1 signaling pathways.\",\n      \"method\": \"Cultured neonatal rat cardiac myocytes; protein synthesis assay (³H-leucine), ANP secretion RIA, EMSA for transcription factor binding, CaM kinase II activity assay, ERK phosphorylation by Western blot, intracellular Ca²⁺ imaging, cGMP measurement; 8-bromo-cGMP as mechanistic probe; PKC activator and Ca²⁺ ionophore experiments\",\n      \"journal\": \"Endocrinology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal assays in primary cardiomyocytes with bidirectional pathway dissection\",\n      \"pmids\": [\"14749356\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Overexpression of NPPC (due to balanced translocation disrupting a negative regulatory element on chromosome 2q37.1) leads to doubled plasma CNP concentration and a Marfanoid overgrowth phenotype in humans; transgenic mice with NPPC overexpression in bone recapitulate this phenotype, directly linking elevated CNP levels to skeletal overgrowth.\",\n      \"method\": \"FISH and array-CGH characterization of translocation; breakpoint cloning and sequencing; plasma CNP measurement by RIA; NPPC mRNA quantification in patient fibroblasts; phenotype analysis of NPPC-overexpressing transgenic mice\",\n      \"journal\": \"Human Mutation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — human genetics plus transgenic mouse model with quantitative CNP measurement; 102 citations\",\n      \"pmids\": [\"17373680\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"A cluster of translocation breakpoints near NPPC in 2q37.1 causes NPPC overexpression in multiple patients with similar overgrowth phenotype, consistent with separation from a negative regulatory element on chromosome 2 as the causative mechanism.\",\n      \"method\": \"Cytogenetic analysis, molecular breakpoint characterization, NPPC expression quantification in patient-derived cells\",\n      \"journal\": \"Human Mutation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple patients with same mechanism; extends prior single-patient finding\",\n      \"pmids\": [\"17676597\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"The lbab mouse mutation (R-to-G substitution in conserved CNP coding region) causes dwarfism by reducing CNP's ability to bind and activate NPR-B: 10-fold more CNP(lbab) is required to compete for receptor binding, and 30- to >100-fold more is required to activate NPR-B in cGMP assays. Molecular modeling suggests the conserved arginine is critical for binding an acidic pocket in NPR-B.\",\n      \"method\": \"Whole-cell cGMP elevation assay, membrane guanylyl cyclase activity assay, radioligand competition binding with [¹²⁵I]CNP, molecular modeling\",\n      \"journal\": \"Peptides\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro receptor binding and enzymatic assays with defined mutant peptide; mechanistic explanation of dwarfism phenotype\",\n      \"pmids\": [\"18554750\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"The lbab/lbab mouse spontaneous mutation is a hypomorphic Nppc mutation retaining only slight CNP activity for cGMP production; transgenic rescue with chondrocyte-specific CNP expression fully compensates the dwarf phenotype, confirming NPPC loss-of-function causes dwarfism through impaired endochondral ossification with markedly reduced proliferative and hypertrophic chondrocyte zones.\",\n      \"method\": \"Transgenic rescue experiment; cGMP production assay for lbab CNP activity; histological analysis of growth plate; bone length measurement\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic rescue definitively links Nppc mutation to phenotype with mechanistic characterization\",\n      \"pmids\": [\"18775416\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"CNP acts as a bifurcation factor for sensory neurons: CNP activates a cGMP signaling cascade via NPR2 (GC-B) that is essential for sensory axon bifurcation at the dorsal root entry zone (DREZ) of the spinal cord, but does not affect collateral formation. In CNP mutant mice, bifurcation errors persist at maturity and result in reduced synaptic input on secondary neurons (measured by patch-clamp).\",\n      \"method\": \"CNP knockout mouse analysis; axon tracing; electrophysiological patch-clamp recordings; genetic comparison with nitric oxide-sensitive guanylyl cyclase (NO-GC) knockouts\",\n      \"journal\": \"Proceedings of the National Academy of Sciences\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic loss-of-function with specific anatomical and electrophysiological phenotype; pathway dissection via NO-GC comparison\",\n      \"pmids\": [\"19805384\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Mural granulosa cells express NPPC mRNA while cumulus cells express NPR2 (GC-B); CNP increases cGMP in cumulus cells and oocytes and inhibits meiotic resumption in vitro. Graafian follicles of Nppc or Npr2 mutant mice fail to sustain meiotic arrest, with precocious meiotic resumption. Oocyte-derived paracrine factors promote cumulus cell NPR2 expression, establishing a granulosa→cumulus→oocyte paracrine signaling axis.\",\n      \"method\": \"In situ hybridization and RT-PCR for Nppc/Npr2 expression; cGMP measurement in cumulus cells and oocytes; in vitro meiosis inhibition assay; Nppc and Npr2 knockout mouse phenotyping; conditioned medium experiments with oocyte-derived factors\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic loss-of-function in two genes with specific cellular phenotype plus in vitro reconstitution; 454 citations\",\n      \"pmids\": [\"20947764\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"The local CNP/GC-B system within the growth plate is responsible for physiological endochondral bone growth: cartilage-specific Nppc or GC-B knockout mice have severely shortened bones comparable to systemic knockouts, with drastically reduced hypertrophic chondrocyte layers and moderately reduced proliferative layers. Circulating CNP from transgenic mice with liver-specific NPPC overexpression can rescue impaired bone growth and reduce mortality of CNP knockout mice, demonstrating that systemic CNP delivery is sufficient.\",\n      \"method\": \"Cartilage-specific conditional knockout mice for Nppc and NPR2 (GC-B); bone length measurement; histological growth plate analysis; BrdU proliferation assay; rescue by SAP-Nppc transgenic mice (systemic CNP); survival analysis\",\n      \"journal\": \"Endocrinology / Scientific Reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — tissue-specific genetic knockouts with mechanistic cellular analysis plus systemic rescue experiment\",\n      \"pmids\": [\"20610569\", \"26014585\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"The pre-ovulatory LH/hCG surge decreases CNP secretion by granulosa cells to promote meiotic resumption: LH/hCG treatment decreases NPPC transcripts in mural granulosa cells and ovarian CNP content; CNP treatment of cumulus-oocyte complexes inhibits meiosis resumption with increased cGMP in both cumulus cells and oocytes. In human ovaries, CNP in follicular fluid decreases following ovulatory hCG dose.\",\n      \"method\": \"Genome-wide microarray analysis of periovulatory ovaries; RT-PCR quantification of NPPC; RIA for ovarian CNP; in vitro meiosis inhibition assay; cGMP measurement; human follicular fluid CNP measurement\",\n      \"journal\": \"Human Reproduction\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple species (mouse and human), multiple methods; mechanistic link from LH to CNP regulation established\",\n      \"pmids\": [\"21865234\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"CNP/NPR2 signaling maintains oocyte meiotic arrest from early antral follicle stages; Npr2 mutant mice show precocious meiotic resumption in early antral follicles. Amphiregulin (an LH/hCG mediator acting via EGFR) suppresses NPPC mRNA levels in cultured granulosa cells, establishing the LH→EGFR→amphiregulin→decreased NPPC→meiotic resumption pathway.\",\n      \"method\": \"In situ hybridization and RT-PCR for Nppc/Npr2 in ovaries at different follicular stages; histological phenotyping of Npr2 mutant mice; hCG treatment of immature mice with quantification of NPPC mRNA; amphiregulin treatment of cultured granulosa cells\",\n      \"journal\": \"Molecular Reproduction and Development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic model plus pharmacological pathway dissection with molecular readouts\",\n      \"pmids\": [\"22987720\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"NPPC/NPR2 signaling is essential for oocyte meiotic arrest and cumulus oophorus formation: Nppc(lbab) and Npr2(cn) mutant mice ovulate oocytes with fragmented/degenerated ooplasm that fail to develop past the two-cell stage; oocytes in antral follicles prematurely resume meiosis with disorganized chromosomes; ovulated oocytes lack cumulus cells.\",\n      \"method\": \"Phenotypic analysis of Nppc and Npr2 mutant mice; histology of ovaries; oocyte developmental competence assay (fertilization and two-cell development)\",\n      \"journal\": \"Reproduction\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — two independent genetic mutants with detailed cellular phenotyping\",\n      \"pmids\": [\"22696190\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"A CNP analog (BMN 111) resistant to neutral endopeptidase (NEP) degradation inhibits MAPK pathway activation (decreased pERK1/2) in human achondroplasia growth-plate chondrocytes and rescues bone growth in Fgfr3(Y367C/+) achondroplasia mice, confirming the CNP→NPR-B→cGMP→MAPK inhibition mechanism as therapeutically relevant.\",\n      \"method\": \"ERK1/2 phosphorylation assay in human achondroplasia chondrocytes; bone growth measurement in Fgfr3 mutant mice treated with BMN 111; skeletal analysis including growth plate histology\",\n      \"journal\": \"American Journal of Human Genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — pharmacological validation in human cells and mouse model; 153 citations\",\n      \"pmids\": [\"23200862\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"CNP infusion in failing rat hearts increases cGMP and produces a negative inotropic response (NIR) and positive lusitropic response (LR) via PKG-mediated phosphorylation of phospholamban (PLB Ser16) and troponin I (TnI Ser23/24); SERCA2 activity is essential for both responses, as shown by SERCA inhibition (thapsigargin) and cardiomyocyte-specific SERCA2 gene inactivation. CNP increases Ca²⁺ transient amplitude and SERCA2 activity.\",\n      \"method\": \"Muscle strip contractility measurements; cGMP level assay; Ca²⁺ transient imaging; Western blot for PLB and TnI phosphorylation; SERCA inhibitor (thapsigargin) experiments; cardiomyocyte-specific SERCA2 knockout mice; PKG blocker experiments\",\n      \"journal\": \"British Journal of Pharmacology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal assays including genetic SERCA2 deletion validating mechanism\",\n      \"pmids\": [\"23808942\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"The local CNP/GC-B system in the growth plate is responsible for physiological endochondral bone growth; cartilage-specific GC-B (NPR-B) knockout mice are shorter than cartilage-specific CNP knockout mice, indicating that GC-B in the growth plate may also respond to signals beyond local CNP.\",\n      \"method\": \"Cartilage-specific conditional knockout mice for Nppc and NPR2 (GC-B); bone length measurement; growth plate histology; comparison with systemic knockouts; BrdU proliferation assay\",\n      \"journal\": \"Scientific Reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — tissue-specific genetic knockouts with quantitative bone analysis\",\n      \"pmids\": [\"26014585\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Two heterozygous NPPC mutations in the conserved CNP ring region cause autosomal dominant short stature in humans; both mutations show significant reductions in cGMP synthesis when tested functionally, confirming loss-of-function pathogenicity. One mutation corresponds to the lbab mouse mutation.\",\n      \"method\": \"NPPC sequencing in 668 patients (357 disproportionate short stature, 311 ISS) plus exome sequencing; cGMP production assay for functional validation of mutant CNP peptides; co-segregation analysis in families\",\n      \"journal\": \"Genetics in Medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — direct functional assay of mutant CNP with cGMP measurement plus human genetic co-segregation\",\n      \"pmids\": [\"28661490\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Elevated circulatory CNP (from liver-specific NPPC transgenic mice) rescues craniofacial hypoplasia in achondroplasia (Fgfr3ach) mice by restoring spheno-occipital synchondrosis thickness, promoting chondrocyte proliferation in craniofacial cartilage, and ameliorating foramen magnum stenosis, demonstrating that systemic CNP promotes endochondral ossification in craniofacial as well as appendicular bone.\",\n      \"method\": \"Fgfr3ach mice crossed with SAP-Nppc-Tg mice (systemic CNP); craniofacial morphometric analysis; synchondrosis histology; chondrocyte proliferation assay\",\n      \"journal\": \"Journal of Dental Research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic rescue experiment with quantitative anatomical analysis\",\n      \"pmids\": [\"28644737\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Tristetraprolin (TTP/ZFP36) mediates LH-surge-induced degradation of Nppc mRNA in mural granulosa cells: LH/hCG transiently upregulates Zfp36 mRNA; TTP directly targets a rare non-canonical AU-rich element in the Nppc 3' UTR to destabilize Nppc mRNA; MGC-specific Zfp36 knockout and lentiviral knockdown impair LH-induced Nppc mRNA decline and oocyte meiotic resumption. LH activates Zfp36/TTP via the EGFR-ERK1/2-dependent pathway.\",\n      \"method\": \"Gain- and loss-of-function of Zfp36 in MGCs; MGC-specific Zfp36 conditional knockout mice; in vivo lentiviral knockdown; RNA-binding assay (TTP binding to Nppc 3' UTR); mRNA stability assay; oocyte meiotic resumption phenotyping; pathway dissection with EGFR-ERK inhibitors\",\n      \"journal\": \"Proceedings of the National Academy of Sciences\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic loss-of-function plus direct RNA-binding assay establishing molecular mechanism of Nppc mRNA regulation\",\n      \"pmids\": [\"34031239\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"CNP, but not BNP, increases cGMP near troponin I (TnI) in addition to phospholamban (PLB) in adult cardiomyocytes, explaining the differential ability of CNP (vs. BNP) to induce both lusitropic and negative inotropic responses. CNP stimulation in t-tubules and on the cell crest both increase cGMP near TnI and PLB similarly; PDE2 and PDE3 constrain cGMP in both compartments. In heart failure cardiomyocytes, CNP increases cGMP near PLB and TnI more than in sham cells.\",\n      \"method\": \"FRET-based targeted cGMP biosensors (PLB-targeted and TnI-targeted); scanning ion conductance microscopy (SICM) for local receptor stimulation; ventricular strip contractility measurements; PDE2/PDE3 inhibitor experiments; comparison of CNP vs. BNP in normal and heart failure rat cardiomyocytes\",\n      \"journal\": \"Cardiovascular Research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — novel FRET biosensors with subcellular resolution; multiple methods including SICM; mechanistic explanation of CNP vs. BNP differential effects\",\n      \"pmids\": [\"33970224\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"CNP exerts antiarrhythmic effects via PDE2 (phosphodiesterase 2): CNP-stimulated cGMP activates PDE2, which hydrolyzes cAMP, reducing catecholamine-mediated arrhythmogenic events, ICaL, INaL, and Ca²⁺ spark frequency. PDE2 inhibition or cardiomyocyte-specific PDE2 deletion abolishes CNP's antiarrhythmic effect. These findings were confirmed in human iPSC-derived cardiomyocytes.\",\n      \"method\": \"Ex vivo perfused mouse hearts (arrhythmia after ischemia/reperfusion); in vivo catecholamine injection in mice; patch-clamp (ICaL, INaL); Ca²⁺ spark imaging; cAMP level measurement; protein phosphorylation (Western blot); cardiomyocyte-specific PDE2 knockout mice; pharmacological PDE2 inhibition; human iPSC-derived cardiomyocytes\",\n      \"journal\": \"Circulation Research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — genetic deletion plus pharmacological inhibition in multiple systems including human iPSC-CMs; mechanistic pathway fully dissected\",\n      \"pmids\": [\"36715019\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"CNP promotes anti-inflammatory macrophage phenotype, efferocytosis, and reduces foam cell formation and necroptosis in atherosclerosis; mechanistically, CNP accelerates HIF-1α degradation by enhancing the interaction between PHD2 (prolyl hydroxylase domain-containing protein 2) and HIF-1α. CD36 binds CNP on the macrophage surface and mediates its endocytosis. CNP supplementation or overexpression reduces atherosclerotic plaque formation in ApoE-/- mice.\",\n      \"method\": \"Proteomics; co-immunoprecipitation (PHD2-HIF-1α interaction); CD36 knockout primary macrophages; endocytosis assay; CNP osmotic pump infusion and genetic overexpression in ApoE-/- mice; LCZ696 (neprilysin inhibitor) treatment; plaque analysis; macrophage functional assays (efferocytosis, foam cell formation, necroptosis)\",\n      \"journal\": \"Circulation Research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — Co-IP for molecular interaction plus CD36 KO macrophages for receptor identification; multiple mechanistic approaches; 38 citations\",\n      \"pmids\": [\"38456298\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Cloned ancestral shark NPR-B receptor activated by CNP increases cGMP (EC50 12 nM) and activates CFTR Cl⁻ channels (EC50 8 nM) when co-expressed in Xenopus oocytes with human CFTR, providing direct evidence that NPR-B/cGMP signaling activates CFTR; CNP increases oocyte cGMP 36-fold and Cl⁻ current 37-fold.\",\n      \"method\": \"Xenopus oocyte co-expression system; cGMP measurement; two-electrode voltage-clamp electrophysiology for Cl⁻ current measurement; receptor cloning and sequence analysis\",\n      \"journal\": \"American Journal of Physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstitution in Xenopus oocytes with quantitative functional measurements\",\n      \"pmids\": [\"9950772\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"CNP activates CFTR-dependent Cl⁻ transport in vivo in mouse nasal airway epithelium via membrane-bound guanylate cyclase activation; CNP effect is absent in CFTR-null mice and present in ΔF508 CFTR mice where CNP plus forskolin synergistically stimulates Cl⁻ secretion.\",\n      \"method\": \"In vivo nasal transepithelial potential difference (TEPD) assay in wild-type, CFTR-/-, and CFTR(ΔF/ΔF) mice; 8-Br-cGMP as positive control; pharmacological dissection\",\n      \"journal\": \"American Journal of Physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo genetic model (CFTR knockout) establishes CFTR-dependence of CNP effect\",\n      \"pmids\": [\"9374736\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"NPR-C receptor activation by CNP (mimicked by selective NPR-C agonist cANF4-23) suppresses leukocyte rolling on venular endothelium and reduces P-selectin expression on endothelial cells, leukocytes, and platelets; CNP also inhibits thrombin-induced platelet aggregation. These anti-inflammatory effects are mediated at least in part through NPR-C-dependent suppression of P-selectin.\",\n      \"method\": \"Intravital microscopy of mouse mesenteric venules (eNOS-/- mice and IL-1β/histamine-induced inflammation); selective NPR-C agonist (cANF4-23) comparison; platelet aggregation assay of human blood; P-selectin expression analysis in HUVEC, leukocytes, and platelets\",\n      \"journal\": \"Proceedings of the National Academy of Sciences\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo intravital microscopy with receptor-selective agonist; multiple cell types and functional assays; 83 citations\",\n      \"pmids\": [\"16179391\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"2q37 deletions including the NPPC gene cause short stature with normal plasma CNP, while deletions that interrupt only the DIS3L2 gene (without involving NPPC) but are associated with elevated plasma CNP cause Marfanoid overgrowth, supporting that NPPC gene dosage directly determines CNP levels and skeletal growth outcome.\",\n      \"method\": \"Array CGH; NPPC gene copy number analysis; plasma CNP measurement by RIA; clinical phenotyping\",\n      \"journal\": \"PLOS ONE\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — human genetics correlating gene dosage with CNP levels and opposite skeletal phenotypes; mechanistic inference from copy number/expression relationship\",\n      \"pmids\": [\"23805197\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"CNP inhibits leukocyte-endothelial interactions and platelet activation via suppression of P-selectin expression; this effect is mediated through NPR-C (not NPR-B/cGMP), as selective NPR-C agonist cANF4-23 mimics CNP's effect.\",\n      \"method\": \"Intravital microscopy; selective receptor agonists; P-selectin expression assay in HUVEC and blood cells; platelet aggregometry\",\n      \"journal\": \"Proceedings of the National Academy of Sciences\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo and in vitro assays with receptor-selective pharmacology; 83 citations\",\n      \"pmids\": [\"16179391\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"CNP suppresses plasminogen activator inhibitor-1 (PAI-1) in vivo in a rabbit carotid artery collar model of intimal hyperplasia; both peri-arterial and intra-luminal CNP reduce PAI-1 in endothelium, adventitia, and neointima, and reduce macrophage infiltration, independently of superoxide.\",\n      \"method\": \"Rabbit carotid collar model; immunohistochemistry and densitometry for PAI-1; Western blot; peri-arterial and intra-luminal CNP delivery; superoxide chemiluminescence assay\",\n      \"journal\": \"Cardiovascular Research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vivo model with quantitative protein measurements; single laboratory\",\n      \"pmids\": [\"15914122\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"CNP (but not ANP or BNP) relaxes human isolated subcutaneous resistance arteries via cGMP-dependent kinase (PKG) activation and opening of large-conductance Ca²⁺-activated potassium (BKCa) channels; this effect is endothelium-independent and not mediated by nitric oxide or soluble guanylate cyclase.\",\n      \"method\": \"Isometric myograph measurements on human subcutaneous resistance arteries; endothelium removal; NOS inhibition (L-NAME); soluble GC inhibitor (ODQ); PKG blocker (Rp-8-Br-cGMPS); high K⁺ and iberiotoxin (BKCa blocker); vasopeptidase inhibitor omapatrilat\",\n      \"journal\": \"Journal of the Renin-Angiotensin-Aldosterone System\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct pharmacological dissection of signaling cascade in human tissue with multiple channel/kinase blockers\",\n      \"pmids\": [\"17083062\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"CNP inhibits spontaneous contraction of guinea pig caecal circular smooth muscle cells via cGMP-dependent activation of calcium-activated potassium currents (IK(ca)), including spontaneous transient outward currents (STOCs); both soluble and particulate guanylate cyclase pathways contribute to CNP-induced relaxation.\",\n      \"method\": \"Smooth muscle strip contractility recording; whole-cell patch-clamp for IK(ca) and membrane potential; guanylate cyclase inhibitors (LY83583); cGMP phosphodiesterase inhibitor (zaparinast); TEA as non-selective K⁺ channel blocker\",\n      \"journal\": \"World Journal of Gastroenterology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 — direct electrophysiology with pharmacological pathway dissection; single laboratory\",\n      \"pmids\": [\"12970905\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Bovine NPR2 is expressed not only in cumulus cells (as in mouse/porcine) but also in oocyte membranes; CNP can directly activate intra-oocyte cGMP production via NPR2 on the oocyte membrane in addition to the cumulus cell-mediated pathway, representing a species-specific mechanism. NPR2 expression in bovine CCs and oocytes is synergistically regulated by estradiol and oocyte-derived growth factors.\",\n      \"method\": \"Immunofluorescence localization of NPR2 in bovine COCs; cGMP measurement in isolated oocytes after CNP treatment; comparison with mouse and porcine; gene expression analysis\",\n      \"journal\": \"Theriogenology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct receptor localization and functional cGMP measurement in oocytes; single laboratory\",\n      \"pmids\": [\"29080478\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"LH and amphiregulin (an EGF-like peptide acting via EGFR) decrease BNP and CNP (NPPC) production in porcine granulosa cells and downregulate NPR2 expression in cumulus cells, together reducing oocyte cGMP to permit meiotic resumption; the effect of AREG on natriuretic peptide signaling and oocyte maturation is completely blocked by EGFR kinase inhibitor AG1478, while LH effect is only partially reversed.\",\n      \"method\": \"Porcine granulosa cell culture; COC co-culture with granulosa cells; EGFR inhibitor (AG1478); RT-PCR and ELISA for NPPC/BNP and NPR2 expression; cGMP measurement; oocyte maturation assay\",\n      \"journal\": \"Molecular Reproduction and Development\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — pharmacological dissection of LH→EGFR→CNP axis in porcine system; single laboratory\",\n      \"pmids\": [\"25348585\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"NPPC-encoded CNP is proteolytically processed from pro-CNP by furin, and acts as a paracrine/autocrine ligand that selectively binds and activates NPR-B (GC-B) guanylyl cyclase receptor to produce cGMP, with subordinate signaling via clearance receptor NPR-C; in bone, CNP/NPR-B signaling promotes endochondral ossification by inhibiting FGFR3-MAPK signaling in growth plate chondrocytes; in the ovary, mural granulosa cell-derived CNP maintains oocyte meiotic arrest via cumulus cell NPR2/cGMP until the LH surge triggers TTP-mediated Nppc mRNA degradation (via EGFR-ERK1/2) to decrease CNP and permit meiotic resumption; in the cardiovascular system, CNP regulates cardiomyocyte contractility by increasing cGMP near troponin I and phospholamban through NPR-B, exerts antiarrhythmic effects via PDE2 activation reducing cAMP, relaxes vascular smooth muscle via PKG-BKCa channels, and suppresses macrophage inflammation by enhancing PHD2-HIF-1α interaction (mediated by CD36-dependent endocytosis); CNP expression in endothelial cells is transcriptionally induced by hemodynamic shear stress through a calcium-dependent mechanism; and in the CNS, CNP acts as a bifurcation factor for sensory axons via NPR2-cGMP signaling.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"NPPC encodes C-type natriuretic peptide (CNP), a secreted signaling peptide that selectively activates the NPR-B (GC-B) receptor guanylyl cyclase to generate cGMP, mediating tissue-specific functions in vascular tone, bone growth, cardiac contractility, oocyte meiotic arrest, and neuronal development [PMID:1672777, PMID:20947764, PMID:14702637, PMID:19805384]. In the ovary, mural granulosa cell-derived CNP maintains oocyte meiotic arrest via NPR2-dependent cGMP elevation in cumulus cells, and the LH surge terminates this signal by inducing TTP/ZFP36-mediated degradation of Nppc mRNA [PMID:20947764, PMID:34031239]. In cartilage, local CNP/GC-B signaling drives endochondral bone growth by antagonizing FGFR3-MAPK signaling, and loss-of-function NPPC mutations cause autosomal dominant short stature in humans [PMID:14702637, PMID:26014585, PMID:28661490]. In cardiomyocytes, CNP generates compartment-specific cGMP pools near phospholamban and troponin I to modulate contractility and exerts antiarrhythmic effects through PDE2-mediated cAMP hydrolysis, while in vascular smooth muscle it induces relaxation via PKG activation and BKCa channel opening [PMID:33970224, PMID:36715019, PMID:17083062].\",\n  \"teleology\": [\n    {\n      \"year\": 1990,\n      \"claim\": \"Establishing that CNP is a potent activator of particulate guanylate cyclase and cGMP production in vascular smooth muscle, distinct from its weak renal effects, defined the vascular specificity of NPPC signaling.\",\n      \"evidence\": \"cGMP measurement and guanylate cyclase assay in cultured rat vascular smooth muscle cells\",\n      \"pmids\": [\"2164803\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Receptor identity not yet resolved\", \"In vivo vascular function not tested\", \"Downstream effectors of cGMP in VSMC not identified\"]\n    },\n    {\n      \"year\": 1991,\n      \"claim\": \"Demonstrating that CNP selectively activates NPR-B (ANPR-B) with 50–500-fold selectivity over NPR-A resolved which receptor mediates CNP signaling and distinguished it from ANP/BNP pathways.\",\n      \"evidence\": \"Receptor binding and cGMP accumulation assays in cells expressing human ANPR-A or ANPR-B\",\n      \"pmids\": [\"1672777\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Tissue-specific receptor expression patterns not mapped\", \"In vivo receptor requirement not tested\"]\n    },\n    {\n      \"year\": 1994,\n      \"claim\": \"Discovery of CNP production by anterior pituitary gonadotropes co-expressing GC-B established an autocrine CNP signaling loop outside the vasculature, broadening the known physiological scope of NPPC.\",\n      \"evidence\": \"Immunohistochemistry for CNP/LH co-localization, GC-B mRNA detection, and targeted gonadotrope ablation in rat pituitary\",\n      \"pmids\": [\"7988473\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional consequence of autocrine CNP in gonadotropes not determined\", \"Role in gonadotropin secretion not tested\"]\n    },\n    {\n      \"year\": 1996,\n      \"claim\": \"Showing that CNP stimulates osteoblast differentiation markers (alkaline phosphatase, osteocalcin, mineralization) via NPR-B/cGMP provided the first evidence that CNP regulates bone cell function.\",\n      \"evidence\": \"cGMP measurement and differentiation assays in primary osteoblast-like cells with 8-bromo-cGMP validation\",\n      \"pmids\": [\"8967430\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo bone phenotype not yet demonstrated\", \"Relationship to endochondral ossification unclear\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"Demonstrating that CNP activates CFTR-dependent Cl⁻ transport via membrane-bound guanylate cyclase in vivo revealed a CNP–cGMP–CFTR signaling axis in epithelial ion transport.\",\n      \"evidence\": \"In vivo nasal potential difference assay in wild-type and CFTR-knockout/ΔF508 mice; Xenopus oocyte reconstitution of shark NPR-B with human CFTR\",\n      \"pmids\": [\"9374736\", \"9950772\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological relevance of CNP-CFTR axis in airway biology not established\", \"Whether this pathway is therapeutically exploitable in CF not determined\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Identifying shear stress as an inducer of NPPC transcription in endothelial cells, dependent on intracellular calcium but independent of NO, established hemodynamic regulation of CNP production.\",\n      \"evidence\": \"Cone-plate shear stress on HUVECs with pharmacological inhibitors (L-NAME, genistein, BAPTA/AM); RT-PCR and ELISA\",\n      \"pmids\": [\"7589445\", \"10468226\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Transcription factor mediating shear-induced NPPC expression not identified\", \"In vivo shear-stress regulation not confirmed\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Genetic rescue of FGFR3-mediated achondroplasia by chondrocyte-specific CNP overexpression established CNP as a physiological antagonist of FGFR3-MAPK signaling in endochondral bone growth.\",\n      \"evidence\": \"Chondrocyte-specific CNP transgenic mice crossed with achondroplasia model; MAPK and STAT-1 pathway analysis\",\n      \"pmids\": [\"14702637\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Precise cGMP-to-MAPK inhibition mechanism not resolved\", \"Whether CNP acts cell-autonomously on all growth plate zones unclear\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Identifying PKG and BKCa channel opening as the downstream effectors of CNP-mediated vasorelaxation in human resistance arteries resolved the smooth muscle signaling pathway and showed it is endothelium-independent.\",\n      \"evidence\": \"Isometric myography on human subcutaneous arteries with PKG and BKCa inhibitors\",\n      \"pmids\": [\"17083062\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Role of NPR-C in vasorelaxation not fully dissected\", \"Contribution relative to NO-mediated relaxation in vivo not quantified\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Characterization of the lbab mouse missense mutation in the CNP ring, showing 10–100-fold reduced NPR-B activation, directly linked reduced CNP bioactivity to dwarfism from impaired endochondral ossification.\",\n      \"evidence\": \"Whole-cell cGMP assay, receptor binding, and transgenic rescue in lbab mice\",\n      \"pmids\": [\"18554750\", \"18775416\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis for binding loss not crystallographically confirmed\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Discovery that CNP knockout mice show persistent sensory axon bifurcation defects expanded CNP function into nervous system development via NPR2/cGMP-dependent axon guidance.\",\n      \"evidence\": \"CNP knockout mouse analysis with axon tracing and patch-clamp electrophysiology\",\n      \"pmids\": [\"19805384\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Downstream cGMP effector (PKG isoform) in axon bifurcation not identified\", \"Whether CNP acts as a graded chemotropic signal or permissive factor not resolved\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Demonstrating that granulosa cell-derived CNP maintains oocyte meiotic arrest via NPR2/cGMP in cumulus cells, with Nppc and Npr2 mutant mice showing precocious meiotic resumption, established the essential paracrine CNP pathway controlling mammalian oocyte maturation.\",\n      \"evidence\": \"In situ hybridization, cGMP assays, and Nppc/Npr2 knockout mouse meiotic phenotyping\",\n      \"pmids\": [\"20947764\", \"22696190\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How cGMP is transferred from cumulus cells to oocyte (gap junction specificity) not fully resolved\", \"CNP regulation during folliculogenesis not characterized\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Showing that the LH surge suppresses NPPC mRNA via the amphiregulin/EGFR pathway in granulosa cells clarified how ovulatory signaling terminates the meiotic arrest signal.\",\n      \"evidence\": \"Granulosa cell culture with hCG/amphiregulin, qPCR, and EGF receptor inhibitor experiments in mouse and porcine systems\",\n      \"pmids\": [\"22987720\", \"25348585\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct transcription factor or mRNA degradation mechanism downstream of EGFR not yet identified at this time point\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Identifying CNP-mediated PKG-dependent phosphorylation of phospholamban and troponin I at distinct subcellular compartments explained its unique negative inotropic and positive lusitropic effects in failing hearts.\",\n      \"evidence\": \"Muscle strip contractility, cGMP/Ca²⁺ measurements, and SERCA2 knockout cardiomyocytes\",\n      \"pmids\": [\"23808942\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How compartment-specific cGMP pools are maintained was not resolved at this point\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Cartilage-specific knockout of Nppc or GC-B phenocopied systemic knockout dwarfism, proving that the bone-growth function of CNP is paracrine/autocrine within the growth plate.\",\n      \"evidence\": \"Cartilage-specific Cre-mediated Nppc and GC-B knockout with bone measurements\",\n      \"pmids\": [\"26014585\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether circulating CNP contributes additively to local CNP in growth plate not quantified\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Identification of heterozygous NPPC ring mutations in human short stature families with reduced cGMP activity established NPPC haploinsufficiency as a cause of autosomal dominant short stature.\",\n      \"evidence\": \"Whole-exome sequencing with functional cGMP assays for mutant CNP peptides and family segregation analysis\",\n      \"pmids\": [\"28661490\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full phenotypic spectrum of heterozygous NPPC mutations not characterized\", \"Genotype-phenotype correlation across multiple families limited\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Demonstrating that CNP enzyme (2',3'-cyclic nucleotide 3'-phosphodiesterase) suppresses RtcB-mediated XBP1 splicing by hydrolyzing 2',3'-cyclic phosphate on RNA termini established a role for CNP in ER stress RNA processing.\",\n      \"evidence\": \"In vitro XBP1 splicing assay and genetic epistasis with CNP, RtcA, and RtcB in cell lines\",\n      \"pmids\": [\"30355738\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Note: this finding concerns the CNP enzyme (CNPase/2',3'-cyclic nucleotide 3'-phosphodiesterase), a distinct gene product from the NPPC-encoded natriuretic peptide; relevance to NPPC gene function per se is unclear\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Identifying TTP/ZFP36 as the mRNA-destabilizing factor that degrades Nppc mRNA via a noncanonical AU-rich element in its 3' UTR completed the LH→EGFR→ERK→TTP→Nppc mRNA decay cascade controlling meiotic resumption.\",\n      \"evidence\": \"MGC-specific ZFP36 knockout, lentiviral knockdown, RNA binding assays, and in vivo hCG challenge in mice\",\n      \"pmids\": [\"34031239\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether other RNA-binding proteins cooperate with TTP on Nppc mRNA not tested\", \"Post-translational regulation of CNP peptide during meiotic resumption not addressed\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"FRET-based subcellular cGMP biosensors revealed that CNP generates cGMP at both PLB and TnI compartments while BNP only at PLB, explaining the unique contractile effects of CNP versus BNP in cardiomyocytes.\",\n      \"evidence\": \"Subcellularly targeted cGMP FRET sensors (PLB- and TnI-targeted) and scanning ion conductance microscopy in adult cardiomyocytes\",\n      \"pmids\": [\"33970224\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physical basis for compartment-restricted NPR-B versus NPR-A signaling not resolved\", \"Role of A-kinase anchoring proteins in compartmentalization not tested\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Demonstrating that CNP's antiarrhythmic effect requires PDE2-mediated cAMP hydrolysis downstream of NPR-B/cGMP, abolished by cardiomyocyte-specific PDE2 deletion, identified the molecular effector linking CNP to arrhythmia suppression.\",\n      \"evidence\": \"Ex vivo ischemia/reperfusion arrhythmia model, cardiomyocyte-specific PDE2 knockout, patch-clamp, and Ca²⁺ spark imaging in mouse and human iPSC-derived cardiomyocytes\",\n      \"pmids\": [\"36715019\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether CNP is released endogenously during ischemia/reperfusion in sufficient concentrations not demonstrated\", \"Therapeutic applicability in human arrhythmias not tested\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Discovery that macrophages internalize CNP via CD36-mediated endocytosis, where it enhances PHD2–HIF-1α interaction to accelerate HIF-1α degradation and suppress inflammation, revealed a receptor-independent intracellular anti-inflammatory mechanism for CNP.\",\n      \"evidence\": \"Proteomics, Co-IP for PHD2–HIF-1α interaction, CD36 knockout macrophages, and ApoE⁻/⁻ mouse atherosclerosis model\",\n      \"pmids\": [\"38456298\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether intracellular CNP acts independently of NPR-B/cGMP signaling not fully dissected\", \"Structural basis of CNP–PHD2 interaction unknown\", \"Relevance to human atherosclerosis not confirmed\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The structural basis for compartment-restricted cGMP signaling by NPR-B in cardiomyocytes, the transcription factors mediating shear-stress induction of NPPC, and the full spectrum of NPPC haploinsufficiency phenotypes in humans remain unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No structural model of NPR-B in membrane nanodomains\", \"Shear-responsive NPPC promoter elements and transcription factors not identified\", \"Clinical phenotypic spectrum of heterozygous NPPC mutations limited to small families\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0048018\", \"supporting_discovery_ids\": [0, 1, 2, 4, 23]},\n      {\"term_id\": \"GO:0009975\", \"supporting_discovery_ids\": [0, 1, 2, 9, 10]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [3, 8, 11, 12]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005576\", \"supporting_discovery_ids\": [0, 1, 2, 23, 27]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"GO:0009975\", \"supporting_discovery_ids\": []},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 1, 2, 9, 10, 11]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [3, 4, 7, 14, 24]},\n      {\"term_id\": \"R-HSA-1474165\", \"supporting_discovery_ids\": [2, 5, 6, 13]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"NPR2\", \"CFTR\", \"CD36\", \"PHD2\", \"ZFP36\", \"PDE2\"],\n    \"other_free_text\": []\n  }\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"mechanistic_narrative\": \"NPPC encodes C-type natriuretic peptide (CNP), a paracrine/autocrine signaling peptide that is proteolytically processed from a 126-amino acid precursor by furin and selectively activates the NPR-B (GC-B) guanylyl cyclase receptor to generate cGMP, with additional signaling through the clearance receptor NPR-C [PMID:1672777, PMID:12736257, PMID:1309330]. In bone, CNP/NPR-B/cGMP signaling is essential for endochondral ossification by promoting chondrocyte proliferation and hypertrophy and antagonizing FGFR3-MAPK signaling; loss-of-function NPPC mutations cause short stature in humans and mice, while gain-of-function (overexpression) produces skeletal overgrowth [PMID:14702637, PMID:28661490, PMID:17373680, PMID:20610569]. In the ovary, mural granulosa cell–derived CNP maintains oocyte meiotic arrest via cumulus cell NPR2/cGMP until the LH surge triggers EGFR–ERK1/2–dependent TTP-mediated degradation of Nppc mRNA, permitting meiotic resumption [PMID:20947764, PMID:34031239]. In the cardiovascular system, CNP modulates cardiomyocyte contractility through PKG-mediated phosphorylation of troponin I and phospholamban, exerts antiarrhythmic effects by PDE2-dependent cAMP hydrolysis, relaxes vascular smooth muscle via PKG–BKCa channels, and suppresses macrophage-driven inflammation by enhancing PHD2–HIF-1α interaction through CD36-mediated endocytosis [PMID:33970224, PMID:36715019, PMID:17083062, PMID:38456298].\",\n  \"teleology\": [\n    {\n      \"year\": 1990,\n      \"claim\": \"Cloning of the NPPC gene and its brain-restricted expression established CNP as a distinct member of the natriuretic peptide family with a potential CNS role, answering whether natriuretic peptides existed beyond ANP and BNP.\",\n      \"evidence\": \"cDNA cloning, sequencing, and Northern blot in rat tissues showing brain-only expression; parallel human gene characterization with peptide identification by HPLC-RIA\",\n      \"pmids\": [\"1702395\", \"2018508\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full tissue distribution beyond brain not yet mapped\", \"Receptor identity unknown\"]\n    },\n    {\n      \"year\": 1991,\n      \"claim\": \"Demonstration that CNP selectively activates NPR-B (GC-B) rather than NPR-A resolved which receptor transduces CNP signals and defined the CNP–NPR-B–cGMP axis as the core signaling pathway.\",\n      \"evidence\": \"cGMP accumulation assays and binding competition in cells expressing recombinant human NPR-A vs. NPR-B; independent quantification of CNP's 50–500-fold selectivity\",\n      \"pmids\": [\"1672777\", \"1309330\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No structural basis for receptor selectivity\", \"Role of NPR-C clearance receptor in CNP signaling unclear\"]\n    },\n    {\n      \"year\": 1996,\n      \"claim\": \"Discovery that CNP stimulates cGMP in osteoblasts and promotes differentiation markers linked CNP to skeletal biology, opening the question of whether CNP regulates bone growth in vivo.\",\n      \"evidence\": \"cGMP, DNA synthesis, alkaline phosphatase, osteocalcin, and mineralization assays in rat calvarial osteoblasts; 8-bromo-cGMP mimicry\",\n      \"pmids\": [\"8967430\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo bone phenotype of CNP loss not yet established\", \"Chondrocyte vs. osteoblast contributions unknown\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Structural determination of the NPR-C–CNP complex revealed how a single CNP molecule induces asymmetric receptor closure, providing the first atomic-level view of natriuretic peptide receptor activation.\",\n      \"evidence\": \"X-ray crystallography at 2.0 Å resolution of NPR-C extracellular domain bound to CNP\",\n      \"pmids\": [\"11533490\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"NPR-B structure with CNP not yet solved\", \"Mechanism of intracellular guanylyl cyclase activation upon ligand binding unresolved\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Identification of furin as the endoprotease processing pro-CNP to mature CNP resolved how the NPPC precursor is activated, distinguishing CNP processing from corin-dependent ANP maturation.\",\n      \"evidence\": \"Furin inhibitor blockade, furin-deficient cell reconstitution, purified furin cleavage, and bioactivity assay in HEK293/LoVo cells\",\n      \"pmids\": [\"12736257\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether other proprotein convertases contribute in specific tissues\", \"Regulation of furin-mediated processing in vivo\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Genetic rescue of achondroplasia-model mice by chondrocyte-specific CNP overexpression demonstrated that CNP opposes FGFR3-MAPK signaling in growth-plate chondrocytes, establishing the mechanistic basis for CNP's role in endochondral ossification.\",\n      \"evidence\": \"Transgenic CNP overexpression in FGFR3-activated mice; bone length measurement; pERK and STAT-1 Western blot\",\n      \"pmids\": [\"14702637\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct cGMP-to-MAPK inhibition intermediates not identified\", \"Downstream effectors of MAPK inhibition in chondrocytes uncharacterized\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Human chromosomal translocations separating NPPC from a negative regulatory element caused CNP overexpression and skeletal overgrowth, directly linking NPPC dosage to human growth regulation and providing the first human genetic evidence for NPPC gain-of-function.\",\n      \"evidence\": \"FISH, array-CGH, breakpoint cloning, plasma CNP by RIA, NPPC mRNA in patient fibroblasts, plus transgenic mouse phenocopying\",\n      \"pmids\": [\"17373680\", \"17676597\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of the distal negative regulatory element not determined\", \"Whether NPPC copy number variation contributes to normal height variation\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Characterization of the lbab hypomorphic Nppc mutation showed that a single conserved arginine in the CNP ring is critical for NPR-B binding, and chondrocyte-specific transgenic rescue proved the dwarfism is cartilage-autonomous.\",\n      \"evidence\": \"Radioligand competition binding, cGMP activation assays with mutant peptide, transgenic rescue, growth-plate histology\",\n      \"pmids\": [\"18554750\", \"18775416\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full structural basis for the arginine–NPR-B interaction\", \"Whether heterozygous Nppc mutations cause milder skeletal phenotypes in mice\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Discovery that mural granulosa cell–derived CNP maintains oocyte meiotic arrest via cumulus cell NPR2/cGMP established a new paracrine signaling axis essential for female fertility, answering how follicles prevent premature meiotic resumption.\",\n      \"evidence\": \"Nppc and Npr2 knockout mice with precocious meiotic resumption; in situ hybridization; in vitro cGMP rescue; oocyte-derived factor regulation of NPR2\",\n      \"pmids\": [\"20947764\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of cGMP transfer from cumulus to oocyte not fully resolved\", \"Identity of oocyte-derived factors regulating NPR2\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Extension of the ovarian CNP model showed that amphiregulin (an EGFR ligand induced by LH) suppresses NPPC mRNA, defining the LH→EGFR→decreased NPPC→meiotic resumption pathway and explaining how the LH surge terminates CNP signaling.\",\n      \"evidence\": \"Amphiregulin treatment of granulosa cells; hCG in vivo; Npr2 mutant phenotyping at early antral stages; CNP analog therapeutic rescue in achondroplasia mice\",\n      \"pmids\": [\"22987720\", \"22696190\", \"23200862\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Post-transcriptional mechanism of NPPC mRNA decay not yet identified at this time\", \"Whether BNP contributes redundantly in porcine systems\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Demonstration that CNP modulates cardiomyocyte contractility via PKG-mediated phosphorylation of phospholamban and troponin I, dependent on SERCA2, established the molecular basis for CNP's negative inotropic and positive lusitropic cardiac effects.\",\n      \"evidence\": \"Muscle strip contractility, Ca²⁺ transient imaging, PLB/TnI phosphorylation Western blot, SERCA2 cardiomyocyte-specific knockout mice, PKG inhibitors\",\n      \"pmids\": [\"23808942\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Subcellular compartmentalization of CNP-stimulated cGMP not yet resolved\", \"Relevance in human heart failure not yet tested\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Identification of heterozygous loss-of-function NPPC mutations in patients with short stature provided the first direct human genetic evidence that NPPC haploinsufficiency causes growth impairment, completing the bidirectional dosage–phenotype relationship.\",\n      \"evidence\": \"NPPC sequencing in 668 patients, cGMP assay of mutant CNP peptides, family co-segregation\",\n      \"pmids\": [\"28661490\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Prevalence of NPPC mutations among all short stature patients unclear\", \"Whether therapeutic CNP analog could rescue human NPPC haploinsufficiency\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Identification of TTP (ZFP36) as the mediator of LH-induced Nppc mRNA degradation via a non-canonical AU-rich element resolved the post-transcriptional mechanism by which the LH surge terminates CNP production and permits oocyte meiotic resumption.\",\n      \"evidence\": \"MGC-specific Zfp36 conditional knockout; lentiviral knockdown; TTP–Nppc 3′ UTR RNA-binding assay; EGFR-ERK inhibitor pathway dissection; oocyte meiotic phenotyping\",\n      \"pmids\": [\"34031239\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether additional RNA-binding proteins contribute to Nppc mRNA regulation\", \"Chromatin-level regulation of NPPC transcription during the LH surge\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Subcellular FRET biosensor imaging revealed that CNP uniquely increases cGMP near both troponin I and phospholamban (unlike BNP), explaining the differential cardiac functional effects of NPR-B vs. NPR-A signaling and their modulation by PDE2/PDE3.\",\n      \"evidence\": \"Targeted cGMP FRET biosensors (PLB- and TnI-targeted); SICM local stimulation; PDE inhibitors; comparison of CNP vs. BNP in sham and heart failure cardiomyocytes\",\n      \"pmids\": [\"33970224\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether compartmentalized signaling differs in human vs. rodent cardiomyocytes\", \"Role of NPR-B membrane localization in cGMP compartmentalization\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Discovery that CNP's antiarrhythmic action operates through PDE2 activation (cGMP→PDE2→cAMP hydrolysis→reduced ICaL, INaL, and Ca²⁺ sparks) defined a cGMP-to-cAMP cross-talk mechanism confirmed by cardiomyocyte-specific PDE2 deletion and human iPSC-CMs.\",\n      \"evidence\": \"Ex vivo ischemia/reperfusion arrhythmia model; in vivo catecholamine challenge; patch-clamp; Ca²⁺ spark imaging; cardiomyocyte-specific PDE2 KO; human iPSC-CMs\",\n      \"pmids\": [\"36715019\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether chronic CNP supplementation provides sustained antiarrhythmic protection\", \"Interaction between PDE2 and PDE3 pathways at therapeutic CNP doses\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Identification of CD36 as a macrophage CNP receptor mediating endocytosis and the PHD2–HIF-1α degradation mechanism expanded CNP's role to anti-inflammatory and anti-atherogenic signaling independent of canonical NPR-B/cGMP.\",\n      \"evidence\": \"Co-IP for PHD2–HIF-1α interaction; CD36 KO macrophages; endocytosis assay; CNP infusion and genetic overexpression in ApoE⁻/⁻ mice; plaque quantification\",\n      \"pmids\": [\"38456298\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether CD36-mediated CNP signaling occurs in non-macrophage cell types\", \"How intracellular CNP (post-endocytosis) physically enhances PHD2–HIF-1α binding\", \"Independence from NPR-B or NPR-C requires further confirmation\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include the structural basis for CNP–NPR-B activation (no co-crystal structure), the identity of the distal negative regulatory element controlling NPPC transcription, the full spectrum of CNP's CNS functions beyond axon bifurcation, and whether CD36-mediated CNP signaling operates independently of canonical natriuretic peptide receptors in vivo.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No NPR-B–CNP co-crystal structure available\", \"Distal NPPC regulatory element not molecularly characterized\", \"CNS functions beyond sensory axon bifurcation poorly defined\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0048018\", \"supporting_discovery_ids\": [0, 4, 5, 19, 27]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [15, 16, 22, 34, 35]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005576\", \"supporting_discovery_ids\": [2, 7, 17, 24]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"GO:0162582\", \"supporting_discovery_ids\": [0, 4, 5, 28, 33, 34]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [15, 20, 23, 27, 30]},\n      {\"term_id\": \"R-HSA-1474165\", \"supporting_discovery_ids\": [22, 24, 26, 32]},\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [21]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [35, 38, 40]},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [14]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"NPR2\", \"NPR3\", \"FURIN\", \"FGFR3\", \"CD36\", \"PDE2A\", \"ZFP36\"],\n    \"other_free_text\": []\n  }\n}\n```"}